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The X-linked Intellectual disability Protein PHF6 Associates with the PAF1 Complex 
and Regulates Neuronal Migration in the Mammalian Brain 
Abstract 
Intellectual disability is a prevalent developmental disorder for which no effective 
treatments are available. Mutations of the X-linked protein PHF6 cause the Bö rjeson–
Forssman–Lehmann syndrome (BFLS) that is characterized by intellectual disability and 
epilepsy. However, the biological role of PHF6 relevant to BFLS pathogenesis has 
remained unknown. Here, I present my dissertation research demonstrating that 
knockdown of PHF6 profoundly impairs neuronal migration in the mouse cerebral cortex 
in vivo, leading to the formation of white matter heterotopias that harbor aberrant patterns 
of neuronal activity. Importantly, BFLS patient specific mutation of PHF6 blocks its 
ability to promote neuronal migration. I also elucidate the mechanism by which PHF6 
drives neuronal migration in the cerebral cortex. PHF6 physically associates with the 
PAF1 transcription elongation complex, and inhibition of PAF1 phenocopies the PHF6 
knockdown-induced migration phenotype in vivo. I further identify Neuroglycan C 
(NGC), a susceptibility gene for schizophrenia, as a critical downstream target of PHF6 
and the PAF1 complex, and I demonstrate that NGC mediates PHF6-dependent neuronal 
migration. These findings define PHF6, the PAF1 transcription elongation complex, and 
NGC as components of a novel cell-intrinsic transcriptional pathway that orchestrates 
neuronal migration in the brain, with important implications for the pathogenesis of 
intellectual disability and potentially other neuropsychiatric disorders. 
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Chapter 1 
Introduction 
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Intellectual disability is a prevalent disorder 
Intellectual disability (ID) is a very prevalent disorder, affecting 1 to 3 percent of 
the general population (Bhasin et al., 2006; Larson et al., 2001). It is defined as a 
condition marked by an intelligence quotient (IQ) of <70, and characterized by impaired 
intellectual functioning and adaptive skills. The severity of intellectual disability is 
further defined as mild (IQ: 50–70), moderate (IQ: 35–49), severe (IQ: 20–34), and 
profound (IQ: <20) intellectual disability. Unfortunately there is currently no treatment 
for intellectual disability, and because ID patients usually need special education program 
and sometimes assistance in carrying out daily activities, it poses a huge social economic 
burden for the society, with an estimated lifetime cost of $1,014,000 per person (2004).  
It was noted from a very early point that intellectual disability is more prevalent 
among males than females (Penrose, 1938). Epidemiological studies repeatedly showed a 
sex bias, with 30–50% excess of males over females, and led to the assumption that much 
of the excess of male MR may be due to X-linked genes (Fishburn et al., 1983; Herbst 
and Miller, 1980). Indeed, both human genetics and functional studies have revealed that 
the X chromosome harbors many genes essential for brain development and homeostasis, 
and since males have only 1 copy of the X chromosome, they suffer from an increased 
susceptibility to intellectual disability. 
X-Linked intellectual disability (XLID) accounts for roughly 5%–10% of 
intellectual disability in males, and mutations of 102 genes have been described that lead 
to XLID (Lubs et al., 2012). These are further divided into syndromic and non-syndromic 
XLIDs. Syndromic ID describes patients with intellectual disability together with somatic, 3 
 
metabolic, or neuromuscular manifestations, whereas non-syndromic ID patients 
typically have intellectual disability alone or with inconsistent abnormalities. 
Recent human genetics studies have contributed significantly to our 
understanding of cognitive disorders. Genetic mappings and genome wide association 
studies have identified numerous genes, when mutated, cause cognitive dysfunction. For 
example, the identification of the FMR1 (Fragile X Mental Retardation) gene clearly 
elucidated the transmission of the disease within Fragile X families (Verkerk et al., 1991). 
Studying the functions of these genes and how they regulate brain development and 
homeostasis, on the other hand, have led to new understanding of the underlying 
pathophysiology of cognitive disorders. For example, studies of FMR1 has revealed 
important roles in the regulation of protein translation in neurobiology, and in particular, 
synapse biology (Wang et al., 2012). Hopefully, a detailed understanding of the function 
of MR genes will lead to novel therapeutic treatments for cognitive disorders.  
The Bö rjeson-Forssman-Lehmann syndrome (BFLS) was initially characterized 
by Mats Bö rjeson et al in 1962 (Borjeson et al., 1962). They described 3 men who 
suffered from severe intellectual disability, hypogonadism, obesity, abnormal faces with 
fatty swelling of the soft tissues and large ears. Two of the 3 patients suffered from 
epilepsy. Notably, none of the females in the family had the syndrome, and only 
moderate mental deficiency was noted in three women, with one woman showing certain 
physical abnormalities in the probands. Based on the inheritance pattern and severity of 
cognitive impairment within the family, they hypothesized that a recessive mutation of an 
X-linked gene likely causes the disease. 4 
 
Over the years, more cases of BFLS patients have been identified, although BFLS 
remains a rare form of syndromic intellectual disability. In general, patients are born with 
normal pregnancy and delivery. Many infants exhibit generalized hypotonia and poor 
feeding. Developmental delay appears very early during postnatal life, usually evident 
after the first birthday. Their ears are enlarged and genitalia are small. In contrast to the 
earliest cases, most BFLS patients exhibit mild to modest intellectual disability and 
epilepsy occurs in a substantial but not major fraction of patients. Female heterozygotes 
may have learning problems and show part of the facial features including shortened toes, 
and thickened and fleshy ears. Nevertheless, most female carriers are spared or show very 
mild symptoms in BFLS (Gecz et al., 2006; Robinson et al., 1983). 
Molecular genetics studies have gone a long way toward identifying the 
underlying genetic cause of BFLS (Baumstark et al., 2003; Lower et al., 2002). Through 
gene mapping approaches, Lower et all identified a number of mutations in the PHD 
finger protein 6 (PHF6) gene in 9 families of BFLS, including a mutation that occurs in 
two independent families. Follow up studies examining additional BFLS families have 
added to the number of mutations along PHF6 that are specifically associated with BFLS 
(Baumstark et al., 2003; Berland et al., 2011; Carter et al., 2009; Turner et al., 2004). 
Multiple missense and truncation mutations of PHF6 were identified in different patients, 
strongly arguing that mutation of PHF6 is likely the cause of BFLS. 
PHF6 belongs to the PHD (plant homeodomain) zinc finger protein family, a 
group of proteins that have been implicated in a variety of biological processes. PHF6 is a 
365 amino acid protein that contains two imperfect PHD zinc finger domains. PHD zinc 
fingers are structurally conserved modules commonly found in proteins that interact with 5 
 
chromatin and mediate protein-protein interactions during gene transcription. The 
chromatin is the combination of DNA and proteins that make up most of the contents of 
the nucleus in a cell. DNA molecules wrap around histone proteins, which help package 
the DNA molecule into the small compartment of the nucleus. In addition, recent studies 
implicate that modification of histones are important regulators of gene transcription. For 
example, acetylation of histone is generally coupled to a relaxed chromatin structure and 
enhanced transcriptional activity. Methylation of histones, however, plays a more diverse 
role in transcriptional regulation. For example, tri-methylation of histone H3 Lysine 4 
(H3K4) residue results in transcriptional activation, whereas tri-methylation of H3K9 
marks transcriptional repression. In sum, the modification status of histones is a critical 
regulator of gene transcription. 
PHD finger proteins regulate transcription in part through recognizing specific 
histone modifications using the PHD domain. The PHD domain contains the Cys4-His-
Cys3 motif that adopts a globular fold and coordinates two Zn
2+ ions. Not surprisingly, 
different PHD fingers recognize different modifications of the histone. For example, the 
double PHD fingers of DPF3b preferentially recognize acetylated lysine 14 at histone H3 
through forming a hydrophobic pocket, while the PHD finger of nucleosome remodeling 
factor (NURF) directly associates with H3K4me3 tails (Wysocka et al., 2006; Zeng et al., 
2010). Therefore, PHD finger containing proteins are generally thought to regulate 
transcription by recognizing specific chromatin marks, and subsequently either 
enzymatically modifying histone tails, or recruiting other protein complexes. 
Although very little is known about PHF6 function and the pathology of BFLS, 
two lines of evidence suggest a neurodevelopmental origin of BFLS. First, symptoms of 6 
 
cognitive dysfunction in BFLS patients are evident from a very early age, suggesting that 
abnormalities in the early brain development might underlie the mental disabilities and 
other neuroendocrine dysfunctions. Secondly, in situ RNA hybridization analysis showed 
that PHF6 is highly expressed in the developing central nervous system (CNS), while 
expression declines along the course of development (Voss et al., 2007). Therefore, I 
hypothesized that PHF6 might play an essential role during early development of the 
CNS, and mutations of PHF6 leads to abnormal development of the brain, which results 
in cognitive dysfunction. 
Development of the cerebral cortex 
The development of the cerebral cortex is a very complicated process involving 
proliferation of progenitors, generation of neurons, migration of neurons into their 
destined location, development and refinement of synaptic connections. Disruption of any 
of these processes would be detrimental to cognitive functions. 
Neuronal migration refers to the directed movement of newly born neurons to 
their final location. The proper migration and positioning of neurons is critical to the 
correct wiring of the nervous system. In the brain, neurons are generated along the 
proliferative neuroepithelium along the neural tube termed the ventricular zone. 
Excitatory pyramidal neurons are generated from the embryonic pallium while 
GABAergic inhibitory neurons originate from the subpallium.  There exist two types of 
migration: radial migration and tangential migration (Marin and Rubenstein, 2003; 
Nadarajah et al., 2001). In the cerebral cortex, pyramidal neurons migrate into the cortical 
plate through radial migration and inhibitory neurons adopt a tangential manner of 
migration initially before switching to radial migration into the cerebral cortex. Here I 7 
 
will mainly focus on the migration of excitatory pyramidal neurons due to the relevance 
to the topic. 
Migration of excitatory pyramidal neurons 
Excitatory neurons in the cerebral cortex are generated through asymmetric 
divisions of progenitors that line the ventricle surface along the developing pallium. After 
neuronal lineage commitment, neurons initially undergo bipolar-to-unipolar transition 
and migrate toward the differentiating cell zones. Although not much is known about the 
mechanisms of movement during this process, time lapse imaging studies showed that 
twisting of the pial process exerts a mechanical pulling force onto the soma, towards the 
subventricular zone (Miyata, 2007; Miyata and Ogawa, 2007). During this stage, reverse 
movement toward the ventricle surface has been observed although its functional 
significance remains unclear.  
Upon reaching the subventricular zone, the neurons start to adopt a multipolar 
morphology. These multipolar cells do not exhibit fixed polarity and instead, extend and 
retract thin processes in various directions dynamically. Time-lapse imaging studies 
suggest that speed of somal movement at this stage is very slow and therefore, it does not 
contribute significantly to overall movement of the cell (Hatanaka and Yamauchi, 2013). 
However, it has been speculated that this is the stage when the neurons sense the 
environmental cues that direct radial migration. Also the tangential movement of neurons 
at this stage is critical for intermingling and dispersion of neurons across cortical columns, 
which might be essential for establishing proper connections of the radial units (O'Rourke 
et al., 1992). 8 
 
Migration along the radial glial fiber starts when the neuron switches from 
multipolar to bipolar morphology, after which nucleokinesis becomes the predominant 
manner of movement. Nucleokinesis is a manner of movement where neurons migrate 
discontinuously, guided by a leading process of constant length (Nadarajah et al., 2001). 
This is a tightly regulated step and a lot of factors are critical for the transit of multipolar-
to-bipolar morphology. Here I will elaborate on a few factors that are critical for 
nucleokinesis mediated neuronal migration. 
First, the protein reelin, secreted by the Cajal-Retzius neurons from the pre-plate, 
is critical for multiple events during neuronal migration. Reelin acts on multiple levels 
that cooperate in promoting migration. Reelin signals through VLDLR and ApoER2 
receptors, leading to phosphorylation of the cytoplasmic adaptor Dab1 in migrating 
neurons. Dab1 is required for detachment of the migrating neuron from the radial glial 
fiber, and loss of Dab1 leads to termination of migration beneath preplate zone (Sanada et 
al., 2004). Reelin stabilizes the leading process through acting on the phosphorylation 
status of cofilin and therefore the actin cytoskeleton (Chai et al., 2009). In addition, 
Reelin also regulates adhesion of neurons to radial glia through the integrin pathway 
(Dulabon et al., 2000; Sanada et al., 2004). Finally, Reelin controls transcription by 
inhibiting the degradation of Notch intracellular domain (Hashimoto-Torii et al., 2008).  
From a cell biological perspective, subcellular organelles play important roles in 
the cytoskeleton reorganizations that are critical for neuronal migration. For example, the 
centrosome orients toward the pia surface before the multipolar-to-bipolar transition. 
Disruption of centrosomal function through inactivation of Centrin 2 or depletion of 
centrosomal proteins block this transition and further migration (de Anda et al., 2010). In 9 
 
addition, extensive remodeling of the cytoskeleton network is critical to the 
morphological and behavioral changes during migration (Heng et al., 2009). Protrusion of 
the leading process occurs concomitantly with actin polymerization, a rather dynamic 
process that requires both assembly and disassembly on the actin filaments (Pollard and 
Borisy, 2003; Theriot and Mitchison, 1991). Polymerization of actin bundles also 
generates protrusive force that enables extension of the membrane (Condeelis, 1993). On 
the other hand, the microtubule network serves as the major scaffold of the cell and the 
tracks on which proteins and mRNA are transported. Neucleokinesis is critically 
dependent on the microtubule network because movement of the soma occurs through a 
cage of microtubules that surround the nucleus. The leading process exerts a pulling force 
onto the microtubule cage which then pulls the nucleus forward (Lambert de Rouvroit 
and Goffinet, 2001; Solecki et al., 2004). The microtubule network directly contributes to 
leading process stabilization, not only through structural support but also through proper 
transport of vesicles along microtubules. Disruption of microtubule-based transport 
machinery including the dynein complex and microtubule associated proteins (MAPs) 
block migration (Shim et al., 2008; Tsai et al., 2007).  Fourthly, adhesion of migrating 
neurons to radial glia provides the scaffold on which the cell moves. The neuron-radial 
glia interaction through integrin signaling is critical for establishing adhesion of the 
leading process to the extracellular matrix (ECM) in the marginal zone (Sekine et al., 
2012). Moreover, gap junctions between the migrating neuron and radial glia participate 
in stabilization of the leading process and somal translocation (Elias et al., 2007). Fifth, 
dynamic membrane trafficking is also necessary for proper glia-directed migration. 10 
 
Inhibition of endocytic pathways block migration through abnormal accumulation of N-
cadherin, which is involved in neuron-glia contact (Kawauchi et al., 2006). 
The application of molecular biology techniques in developmental neurobiology 
has greatly advanced our knowledge of molecular mechanisms of brain development. The 
use of transgenic mice, including knockouts and knockins, and the development of in 
utero electroporation approach, has enabled efficient genetic manipulation in the 
developing brain. As a result, key molecular mechanisms critical for brain development 
have been identified. The in utero electroporation, a method of delivering DNA plasmids 
into the embryonic brain, has emerged as a useful tool for studies of molecular functions 
during brain development. In addition to its rapid turnaround and wide range of 
functional readouts, a huge advantage of this approach is that transfected cells represent 
only a very small percent of the whole brain. In other words, transfected cells are grown 
in an otherwise normal environment. Therefore, compared to the traditional knockout 
approach, in utero electroporation is a powerful tool where one can examine the cell-
autonomous effect of genetic manipulation on transfected cells. 
Transcriptional regulation of neuronal migration 
Although previous studies have mostly focused on factors regulating the 
cytoskeleton and cell-cell interaction, it is becoming clear that transcriptional regulation 
is also a key component of regulation of neuronal migration. In particular, several 
transcription factors have been shown to play a key role in directing radial migration 
within the developing cerebral cortex. 11 
 
The bHLH transcription factor Ngn2 and the POU-domain transcription factors 
Brn1 and Brn2 are good examples of transcriptional regulators that contribute to cortical 
neuron migration. Ngn2 is thought to promote migration of cortical neurons in part by 
inducing the formation of a polarized leading edge and regulating the expression of Dcx, 
RhoGAPs, RhoA, the Rho GTPase Rnd2, and the Cdk5 activator p35 (Chen et al., 2009; 
Ge et al., 2006; Heng et al., 2008). Brn1 and Brn2 control cortical radial migration by 
directly stimulating the expression of Dab1 and the Cdk5 activators p35 and p39, which 
engage in reelin-dependent signaling and nucleokinesis, respectively (McEvilly et al., 
2002; Sugitani et al., 2002). Therefore, these studies suggest that Brn1 and Brn2 regulate 
migration by controlling the expression of multiple downstream effectors of reelin 
signaling.  
Epigenetic regulation of transcription is a recent topic that received a lot of 
attention. It is based on the finding that histone and DNA molecules are covalently 
modified at multiple locus, and more importantly, the modifications can lead to 
conformational changes of chromatin, rendering it either compact or loose (Strahl and 
Allis, 2000). The conformational changes further influence the accessibility of DNA 
molecules wrapped by the histones, therefore regulating transcription. In addition, the 
histone or DNA modifications are able to recruit effector proteins that mediate the 
downstream effects (Lauberth et al., 2013). Epigenetic proteins regulate transcription 
through either directly or indirectly modulating histones or DNA molecules(Greer and 
Shi, 2012). Given the established role of transcription factors in neuronal developoment, 
it would be interesting to examine the role of epigenetic proteins in neuronal 
development.   12 
 
 
 
 
Chapter 2 
 
 
PHF6 plays an essential role in radial neuronal migration in 
the cerebral cortex in vivo    13 
 
Introduction 
Intellectual disability is a devastating cognitive disorder where no treatment is 
available. Therefore, there is a huge need to understand the underlying pathophysiology 
of intellectual disability.  
Various  abnormalities  of  early  brain  development  are  usually  associated  with 
intellectual disability, and in a lot of cases, are key contributing factors of the disease 
symptoms. For example, abnormalities associated with progenitor cell proliferation can 
lead to microcephaly or macrocephaly (Mahmood et al., 2011). Alterations of neuronal 
migration result in accumulation of neurons in ectopic locations in the cerebral cortex 
(Liu, 1007). In addition, defective axonal, dendritic and synaptic development impairs 
neuronal connectivity, which in turn impair brain function on  a circuit level (Chechlacz 
and Gleeson, 2003). Therefore, studying the role of intellectual disability genes during 
early  brain  development  should  provide  important  information  regarding  the 
pathogenesis of the disease. 
Human genetic studies have firmly established PHF6 as the causative gene for the 
Bö rjeson-Forssman-Lehmann  syndrome.  Multiple  mutations,  including  missense, 
nonsense and insertion/deletion mutations, have been identified in independent families 
of BFLS. However, the functions of PHF6 relevant to BFLS remain unknown.  Since 
previous in situ hybridization studies suggest a high level of PHF6 expression during 
embryonic brain development,  I reasoned that PHF6 might play a critical role  in the 
development of the cerebral cortex (Voss et al., 2007). 
In this chapter, I carried out functional studies of PHF6 in the developing cerebral 
cortex. Using RNAi-mediated gene silencing  approach,  I  uncovered a  critical  role of 
PHF6 in regulating neuronal migration in the cerebral cortex. Knockdown of PHF6 leads 
to massive neuronal migration arrest, and patient mutations of PHF6 block its ability to 14 
 
promote  neuronal  migration.  Therefore,  I  uncovered  a  pathophysiologically  relevant 
function of PHF6 in BFLS.   15 
 
Results 
To interrogate PHF6 function in the mammalian brain, I first characterized the 
expression of PHF6 in the developing cerebral cortex. I found that PHF6 was highly 
expressed  during  early  phases  of  cortical  development  (Figure  2-1).  In  primary  rat 
cortical neurons, PHF6 levels peaked between day 1 in vitro (DIV1) to DIV3, a period 
when  neurons  are  actively  polarizing  and  extending  neurites  (Figure  2-1A).    In  the 
developing mouse brain, PHF6 protein was highly expressed throughout the period of 
corticogenesis, declined in the first postnatal week, and became barely detectable in the 
adult  cerebral  cortex (Figure 2-1B). PHF6 was  found to  be  broadly expressed  in  the 
ventricular and subventricular zones (VZ/SVZ), intermediate zone (IZ), and cortical plate 
(CP) in embryonic day 17 (E17) mouse cortex (Figure 2-1C). The temporal profile of 
PHF6  expression  raised  the  possibility  that  PHF6  might  play  a  role  in  cortical 
development. 
 
   16 
 
 
Figure 2-1. PHF6 is highly expressed during early development of the cerebral cortex. (A-B) 
Lysates of primary rat cortical neurons (A) or mouse cerebral cortex (B) were immunoblotted 
with the PHF6 and 14-3-3 antibodies. (C) Immunohistochemical analyses of the cerebral cortex 
in E17 mouse embryos with the PHF6 and neuron-specific - tubulin type III (Tuj1) antibodies. 
Scale bar: 50m in (C). 
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To  determine  PHF6  function  in  cortical  development,  I  used  a  plasmid-based 
method  of  RNA  interference  (RNAi)  to  acutely  knockdown  PHF6  in  the  developing 
cerebral cortex (Gaudilliere et al., 2002). I designed three short hairpin RNAs (shRNAs) 
targeting distinct regions of PHF6 mRNA, and confirmed that expression of these three 
shRNAs  induced  the  knockdown  of  exogenous  PHF6  protein  in  Human  Embryonic 
Kidney 293 cells (293T cells) and endogenous PHF6 in primary mouse cortical neurons 
(Figures 2-2A, 2-2B, 2-2D, and 2-2F). In addition, I confirmed that introducing these 
shRNAs in vivo during development of the cerebral cortex similarly induced efficient 
knockdown of PHF6 in vivo (Figures 2-2C and 2-2E).  
   18 
 
 
Figure  2-2.  Validation  of  shRNA-mediated  knockdown  of  PHF6.  (A)  Lysates  of  293T  cells 
transfected with an expression plasmid encoding FLAG-PHF6 together with an RNAi plasmid 
encoding PHF6 shRNAs or control scrambled shRNAs were immunoblotted with the FLAG and 
14-3-3 antibodies. Two exposures (short and long) are shown for PHF6. (B) Lysates of primary 
mouse cortical neurons infected with lentivirus expressing PHF6 shRNAs or control scrambled 
shRNAs were immunoblotted with the PHF6 and 14-3-3 antibodies. (C) E14 mouse embryos 
electroporated with an RNAi plasmid encoding PHF6 shRNAs or control scrambled shRNAs 
together with a GFP expression plasmid were allowed to develop until E19. The cerebral cortex 
from the E19 embryos was subjected to immunohistochemical analyses with the PHF6 and GFP 
antibodies.  PHF6  RNAi  induced  robust  downregulation  of  PHF6  in  cortical  neurons  in  vivo 
(arrow heads). (D) Primary rat cortical neurons were transfected DIV0 with an RNAi plasmid 
encoding PHF6 shRNAs or control scrambled shRNAs together with GFP expression plasmid,  19 
 
Figure 2-2. continued 
and  were subjected to  immunocytochemistry  analyses  with  the  PHF6  and  GFP  antibodies  at 
DIV3.  PHF6  RNAi  substantially  reduced  PHF6  immunoreactivity  in  cortical  neurons.  (E) 
Quantification of the percentage of GFP positive neurons as treated in (C) that were positive for 
PHF6 immunoreactivity is presented as mean + SEM. PHF6 RNAi significantly reduced the 
percentage of GFP positive neurons that were PHF6 positive. (F) Quantification of the percentage 
of  GFP  positive  neurons  as  treated  in  (D)  that  were  positive  for  PHF6  immunoreactivity  is 
presented as mean + SEM. PHF6 RNAi significantly reduced the percentage of GFP positive 
neurons that were PHF6 positive in the cerebral cortex in vivo. Scale bar: 3m in (C), 10m in 
(D). 
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I next employed an in utero electroporation method to induce the knockdown of 
PHF6 in the developing mouse cerebral cortex in vivo (Figure 2-3). The PHF6 RNAi 
plasmids were electroporated together with a plasmid encoding GFP in the developing 
cortex  in  mice  at  E14,  when  superficial  layer  neurons  are  generated.  Embryos  were 
allowed  to  develop  in  utero  until  E19,  and  brains  were  harvested  and  subjected  to 
immunohistochemical  analyses.  Upon  characterizing  the  consequences  of  PHF6 
knockdown  on  the  development  of  the  cerebral  cortex,  I  found  a  striking  migration 
phenotype.  Neurons  in  control  animals  differentiated  and  migrated  properly  to  the 
superficial  layers  of  the  cortical  plate  (Kawauchi  et  al.,  2006).  By  contrast,  cortical 
neurons in PHF6 knockdown animals failed to migrate to their proper location in the 
upper cortical plate (Figures 2-4A and 2-4B). Rather, PHF6 knockdown cortical neurons 
accumulated  in  the  intermediate  zone  or  lower  cortical  plate.  Quantification  of  the 
percentage  of  neurons  in  different  regions  revealed  that  PHF6  RNAi  reduced  the 
percentage of neurons reaching the upper cortical plate by 2- to 3-fold, and increased the 
number of neurons in the intermediate zone by 3- to 5-fold. Notably, the extent of the 
migration defect in the PHF6 knockdown animals correlated with the degree of PHF6 
knockdown (Figure 2-2A). In control analyses, I confirmed that the migration defect in 
PHF6 knockdown animals was not secondary to impaired neuronal differentiation (Figure 
2-5A, 2-5F, 2-5G, 2-5H), altered progenitor cell proliferation (Figure 2-5B, 2-5C), effects 
on  general  cell  health  (Figures  2-5D,  2-5E)  or  changes  of  radial  glial  fiber  structure 
(Figure 2-5I). Taken together, these results suggest that PHF6 knockdown profoundly 
and specifically impairs the radial migration of neurons in the developing cerebral cortex. 21 
 
 
Figure  2-3.  A  diagram  of  in  utero  electroporation.  DNA  (green)  is  injected  into  the  lateral 
ventricles of E14 mouse embryos, and electroporation is performed to transfect the DNA into the 
developing cerebral cortex. 
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Figure 2-4. PHF6 knockdown impairs neuronal migration in the cerebral cortex. (A) E14 mouse 
embryos were subjected to in utero electroporation and the cerebral cortex of E19 embryos was 
analyzed by immunohistochemistry using the GFP antibody. PHF6 knockdown in the cerebral 
cortex in vivo profoundly impaired the radial migration of cortical neurons. upCP, upper cortical 
plate; loCP, lower cortical plate; IZ, intermediate zone; VZ/SVZ, ventricular zone/sub-ventricular 
zone. (B) Quantification of the percentage of GFP positive neurons in distinct regions of the 
cerebral cortex in E19 mouse embryos treated as in (A) is presented as mean + SEM. PHF6 RNAi  23 
 
Figure 2-4. continued 
significantly  reduced  the  percentage  of  neurons  that  reached  the  upper  cortical  plate,  and 
concomitantly increased the percentage of neurons stalled in the intermediate zone. Scale bars: 
50m in (A). 
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Figure 2-5. PHF6 knockdown induced migration phenotype is not due to abnormal neuronal 
differentiation, alterations of proliferation or cell death. (A) E14 mouse embryos were 
electroporated and allowed to develop until E19. The cerebral cortex from the E19 embryos was  29 
 
Figure 2-5. continued 
subjected to immunohistochemical analyses with the GFP and the neuron-specific -tubulin type 
III (Tuj1) antibodies. Cells transfected with PHF6 shRNAs were positive for the neuron-specific 
marker (arrowheads). (B) E14 mouse embryos were electroporated and pregnant dams were 
pulsed with BrdU (100g/g body weight) at E17 for 2hr before harvest. Quantification of the 
percentage of GFP positive cells that were BrdU positive in VZ/SVZ of E17 mouse embryos is 
presented as mean + SEM. PHF6 knockdown did not significantly affect incorporation of BrdU in 
progenitor cells. (C) E14 embryos were electroporated as in (A) and harvested at E17. The 
cerebral cortex from the E17 embryos were subjected to immunohistochemical analysis with the 
GFP and phospho-histone H3 (pH3) antibodies. Quantification of the percentage of GFP positive 
cells that were pH3 positive in E17 embryos is presented as mean + SEM. PHF6 knockdown did 
not significantly affect the percent of pH3 positive cells among the progenitor cells. (D) E14 
mouse embryos were electroporated as in (A) and allowed to develop until E19. The cerebral 
cortex from the E19 embryos was subjected to immunohistochemical analyses with the GFP and 
cleaved caspase 3 antibodies. For PHF6 shRNAs, cells in the intermediate zone are shown. (E) 
Quantification of the percentage of GFP positive cells that were cleaved caspase 3 negative or 
positive in E19 embryos treated as in (D) is presented as mean + SEM. (F) Primary rat cortical 
neurons were transfected DIV0 with an RNAi plasmid encoding PHF6 shRNAs or control 
scrambled shRNAs together with GFP expression plasmid, and were subjected to 
immunocytochemistry analyses with the GFP and Tuj1/DCX/NeuN antibodies at DIV3. The 
percentage of GFP positive cells that are positive for the indicated markers is quantified on the 
right. PHF6 knockdown does not affect the differentiation status of cortical neurons. (G-H) E14 
mouse embryos were electroporated as in (A) and allowed to develop until E19. The cerebral 
cortex from the E19 embryos was subjected to immunohistochemical analyses with the GFP and 
Cux1 antibodies. PHF6 knockdown neurons are positive for Cux1, suggesting that they are  30 
 
Figure 2-5. continued 
properly differentiated to occupy the superficial layers of the cerebral cortex. (I) E14 mouse 
embryos were electroporated as in (A) and allowed to develop until E19.PHF6 knockdown does 
not significantly affect the radial glial scaffold. Scales: 5m in (A), 20m in (D), 10m in (F), 
50m in (G) and (I), 30m in (H). 
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To determine whether the PHF6 RNAi-induced migration phenotype is due to 
specific knockdown of PHF6 rather than off-target effects of RNAi, I performed a rescue 
experiment. I used an expression plasmid encoding rat PHF6 (PHF6-Res), which contains 
two mismatches with shRNA-2 targeting mouse PHF6. Whereas expression of mouse 
PHF6 (PHF6-WT) was effectively downregulated by PHF6 RNAi, expression of PHF6-
Res was refractory to PHF6 RNAi (Figure 2-6A). I next determined the effect of PHF6-
Res expression on neuronal migration in the background of PHF6 knockdown in the 
cerebral cortex in vivo. I found that expression of PHF6-Res in PHF6 knockdown animals 
largely restored the normal migration pattern of cortical neurons (Figures 2-6C and 2-6D). 
These data indicate that the PHF6 RNAi-induced migration phenotype is the result of 
specific knockdown of PHF6. 
I next asked whether the migration phenotype induced by PHF6 knockdown is 
relevant to intellectual disability. The rescue experiment allowed in structure-function 
analyses  the  assessment  of  the  effect  of  BFLS  patient  specific  mutations  on  PHF6 
function in neuronal migration. I focused on the patient mutation C99F, because cysteine 
99 is a highly conserved and critical residue in PHF6’s first PHD finger domain (Lower 
et al., 2002) (Figure 2-6B). Strikingly, I found that the C99F mutation blocked the ability 
of PHF6-Res to drive neuronal migration in the cerebral cortex in vivo in the background 
of PHF6 RNAi (Figures 2-6C and 2-6D). Similarly, deletion of 86 amino acids at the C-
terminus of PHF6, a mutation identified in a female patient of BFLS, also blocked its 
ability to  promote neuronal  migration  (Berland et  al.,  2011). These data suggest  that 
PHF6 function in neuronal migration is perturbed by BFLS patient mutations, and thus 
impaired neuronal migration might underlie the pathogenesis of BFLS. 
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Figure 2-6 PHF6 knockdown induced migration arrest is specifically due to loss of PHF6, and is 
pathophysiologically relevant. (A) Lysates of 293T cells transfected with an expression plasmid 
encoding FLAG-rat PHF6 (PHF6-Res) or FLAG-mouse PHF6 (PHF6-WT) together with the 
PHF6 RNAi or control RNAi plasmid were immunoblotted with the FLAG and 14-3-3 
antibodies. Expression of PHF6-Res is refractory to PHF6 RNAi. (B) Protein sequences of human,  33 
 
Figure 2-6. continued 
mouse and rat PHF6 are aligned and cysteine 99 residue is labeled red. This cysteine residue is 
highly conserved across the three species. (C) E14 embryos were electroporated and analyzed as 
in Figure 2-3A with the PHF6 RNAi or control RNAi plasmid together with an expression 
plasmid encoding wild type or the C99F mutant, or deletion 279-365 PHF6-Res protein or the 
corresponding control vector. vec, control vector; Res, PHF6-Res. (D) Quantification of the 
percentage of GFP positive neurons in distinct regions of the cerebral cortex in E19 mouse 
embryos treated as in (G) is presented as mean + SEM. Expression of PHF6-Res significantly 
reduced the percentage of neurons stalled in the intermediate zone and significantly increased the 
percentage of neurons that reached the upper cortical plate in the background of PHF6 RNAi in 
the cerebral cortex in vivo. The C99F mutation and the deletion 279-365 mutation blocked the 
ability of PHF6-Res to drive neuronal migration. Scale bars: 50m in (C).   34 
 
Having established a critical role of PHF6 in neuronal migration, I next asked 
how PHF6 functions in neurons at the cellular level. Radial neuronal migration in the 
cerebral  cortex  results  from  major  cell  morphological  rearrangements,  including  the 
transition from multipolar to bipolar neuronal morphology in the intermediate zone and 
extension of the leading process toward the pia (Ayala et al., 2007; Elias et al., 2007; 
Kerjan  and  Gleeson,  2007;  Kriegstein  and  Noctor,  2004;  Nadarajah  et  al.,  2001). 
Knockdown  of  PHF6  substantially  increased  the  number  of  multipolar  neurons  and 
concomitantly reduced the number of bipolar neurons in the intermediate zone in the 
cerebral  cortex  in  E17  embryos  (Figures  2-7A,  2-7B,  2-7C).  The  multipolar  neurons 
displayed a few short, highly branched processes with multiple orientations. Notably, the 
remaining bipolar neurons in the PHF6 knockdown embryos harbored a thick leading 
process  with  numerous  filopodia-like  protrusions  (Figures  2-7C  and  2-7D).  I  also 
characterized the morphology of the leading process in migrating neurons in the lower 
cortical plate in E19 embryos. PHF6 knockdown dramatically increased the number of 
neurons  that  lacked  the  leading  process  or  that  had  a  short,  poorly  developed,  or 
aberrantly-branched leading process (Figures 2-7E and 2-7F). Collectively, these data 
suggest  that PHF6  plays  a critical  role in  the  multipolar-to-bipolar transition  and the 
morphogenesis of the leading process in migrating neurons. 
   35 
 
 
Figure 2-7. PHF6 is important for the morphological changes during neuronal migration. (A) E14 
embryos were electroporated and allowed to develop until E17. The cerebral cortex from the E17 
embryos was subjected to immunohistochemistry with the GFP antibody. CP, cortical plate. (B) 
Quantification of the percentage of GFP positive neurons in distinct regions of the cerebral cortex  36 
 
Figure 2-7. continued 
in E17 mouse embryos as treated in (A) is presented as mean + SEM. PHF6 knockdown in the 
cerebral cortex in vivo significantly reduced the percentage of neurons that reached the cortical 
plate and concomitantly increased the percentage of neurons stalled in the intermediate zone. (C) 
E14 embryos were electroporated and analyzed as in (A). Representative images for neurons in 
the lower or upper intermediate zone are shown. loIZ, lower intermediate zone; upIZ, upper 
intermediate zone. (D) Quantification of the percentage of GFP positive neurons in the 
intermediate zone exhibiting bipolar or multipolar morphology in E17 mouse embryos treated as 
in (C) is presented as mean + SEM. PHF6 knockdown in the cerebral cortex in vivo significantly 
increased the percentage of multipolar cells in the IZ. (E) E14 embryos were electroporated as in 
(A) and allowed to develop until E19. The cerebral cortex from the E19 embryos was subjected to 
immunohistochemistry with the GFP antibody. Representative images of migrating neurons in the 
lower cortical plate are shown. PHF6 knockdown in the cerebral cortex in vivo leads to loss or 
aberrant branching of the leading process, which is indicated by arrows. (F) Quantification of the 
percentage of GFP positive cells exhibiting different leading process morphologies in E19 
embryos treated as in (E) is presented as mean + SEM. PHF6 knockdown significantly reduced 
the percentage of cells bearing a normal leading process. Scale bar: 50m in (A), 5m in (C), 
10m in (E).37 
 
Discussion 
In this chapter, I identified a critical role of PHF6 in the regulation of neuronal 
migration. Loss of PHF6 during cortical development, induced by RNAi-mediated gene 
silencing, leads to profound impairment of neuronal migration. Moreover, this is likely to 
be pathologically relevant because PHF6 patient mutants fail to promote neuronal 
migration. Taken together, my results suggest that abnormal neuronal migration 
represents a key component of the pathophysiology of BFLS. 
The finding that PHF6 is critical to neuronal migration is somewhat unexpected. 
Although prior to our studies nothing was known concerning the cellular function of 
PHF6, it was speculated to regulate cell growth and proliferation. This is based on its 
genetic linkage to acute myeloid leukemia, where mutations of PHF6 were identified in 
the leukemia cells (Van Vlierberghe et al., 2010). In the literature, both macrocephaly 
and microcephaly have been documented in BFLS patients, and there is no consensus on 
whether changes in brain size are a typical presentation of BFLS patients (Gecz et al., 
2006). Therefore it is unclear whether alterations of brain size are a pathological feature 
of BFLS. 
In  our  system,  it  is  unclear  whether  PHF6  is  critical  for  progenitor  cell 
proliferation in the cerebral cortex. Our data regarding the effect of PHF6 knockdown on 
proliferation is equivocal and therefore I cannot reach a conclusion. However, this also 
argues  that  the  migration  arrest  is  unlikely  due  to  alterations  of  progenitor  cell 
proliferation. Therefore, our data support a specific function of PHF6 in the regulation of 
neuronal migration. 
The pathology of BFLS is very poorly documented. Examination of one of the 
probands  described  in  the  earliest  families  of  BFLS  disease  revealed  cerebral 
malformation  with  clear  though  not  profound  abnormalities  mainly  due  to  disturbed 38 
 
migration  (Brun  et  al.,  1974).  In  particular,  the  cerebral  cortex  showed  widespread 
cortical dysplasia with large areas of indistinct or absent lamination, a critical feature of 
neuronal migration disorders. Therefore, the pathological findings, together with our data 
regarding the patient mutants, suggest that our findings are of critical relevance to the 
pathogenesis of BFLS syndrome. 
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Methods 
Animals 
Timed pregnant CD-1 mice were purchased from Charles River Laboratories. All 
animal experiments were conducted under the institutional guidelines and were approved 
by the Institutional Animal Care and Use Committee (IACUC). 
 
Plasmids 
The PHF6 plasmids were generated by PCR using mouse or rat cortical neuron 
cDNA.  The  shRNA  plasmid  targeting  sequences  are:  control: 
TACGCGCATAAGATTAGGGTA;  PHF6shRNA-1  (mouse): 
GTTCAGCTCACAACAACATCA;  PHF6shRNA-1  (rat): 
GTGCAGCTCACAACAACATCA;  PHF6shRNA-2  (mouse): 
AAGTAGCTCCTACCGAGATAG;  PHF6shRNA-2  (rat): 
AAGCAGTTCCTACCGAGATAG; PHF6shRNA-3: AACTGTACTTCAGGAGATTAA; 
Different shRNA targeting sequences were designed due to differences between mouse 
and rat coding sequences. 
 
In utero electroporation 
In utero electroporations were performed as described (Ge et al., 2010). Briefly, 
venus  plasmid  (final  concentration  0.5ug/ul)  was  co-injected  with  the  RNAi  plasmid 
(final concentration 2ug/ul) into the lateral ventricle of E14 mouse embryos within the 
uterine sac, and electroporation was performed (35V for 50ms, with 950ms intervals, 6 
pulses). The uterine sac was then returned to the abdominal cavity and the abdominal 
wall was sutured. E19 embryos were harvested and fixed in 4% paraformaldehyde for 1hr. 
P6 brains were fixed by intracardiac perfusion using 4% paraformaldehyde followed by 
post-fixation in 4% paraformaldehyde for 2hr. After fixation, brains were subjected to 40 
 
cryoprotection in 30% sucrose in PBS overnight. Afterwards, brains were embedded in 
OCT and flash-frozen, and 20 m coronal sections were prepared. At least 3 animals 
were analyzed for each condition. 
 
Immunoblotting 
Immunoblotting was performed as described (Lehtinen et al., 2006). The PHF6 
(Novus Biologicals), 14-3-3(Santa Cruz) antibodies were used. 
 
Immunohistochemistry 
Cortical sections were rehydrated in PBS for 30min, followed by incubation in 
blocking solution (10% goat serum, 3% BSA, 0.5% Triton X-100 in PBS) for 30min at 
room temperature. Subsequently, sections were incubated in primary antibodies diluted in 
blocking solution overnight at 4° C. The PHF6 (Novus Biologicals), Tuj1 (Covance), GFP 
(chicken,  Abcam)  and  Cux1  (Santa  Cruz)  antibodies  were  used.  Sections  were  then 
washed  three  times  with  PBS  and  incubated  with  appropriate  secondary  antibodies 
conjugated to Alexa 488 or Cy3 (1:1000,Jackson ImmunoResearch), followed by staining 
with  the  DNA  dye  bisbenzimide.  Sections  were  mounted  with  fluoromount-G 
(SouthernBiotech) for fluorescence microscopy. 
 
Immunocytochemistry 
Primary  cultured  neurons  were  fixed  in  4%  paraformaldehyde  for  5-20min 
followed  by  permeabilization  using  0.4%  Triton  X-100  in  PBS.  Samples  were  then 
blocked  in  blocking  solution  containing  10%  milk  and  1%  goat  serum,  followed  by 
staining with primary and secondary antibodies. The PHF6 (Novus Biologicals), Tuj1 
(Covance), GFP (chicken, Abcam), NeuN (Millipore) and Cux1 (Santa Cruz) antibodies 
were used. 
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Lentivirus 
shRNA  sequences  were  cloned  into  pLentiLox  3.7  vector  and  lentivirus 
production was performed as described (Rubinson et al., 2003). 
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Chapter 3 
 
The PAF1 complex interacts with PHF6 and plays a critical 
role in radial migration of neurons in the cerebral cortex in 
vivo 
   44 
 
Introduction 
In the previous chapter, I described functional characterization of PHF6 during 
embryonic brain development. I identified a critical function of PHF6 in the regulation of 
neuronal  migration,  and  uncovered  an  intimate  link  between  this  function  and  the 
pathophysiology of intellectual disability in BFLS. 
In  this  chapter,  I  will  explore  the  molecular  mechanisms  by  which  PHF6 
functions. I hypothesized that PHF6 functions through interacting with other proteins, 
because it does not seem to bear any enzymatic activity by itself. To test this hypothesis, I 
adopted  the  unbiased  immunoprecipitation  followed  by  mass  spectrometry  (IP-MS) 
approach to  search  for  interacting partners of  PHF6. This  approach is very powerful 
because  it  allows  us  to  compare  a  specific  IP-MS  dataset  with  hundreds  of  IP-MS 
datasets  that were performed in  a similar manner, thereby  effectively eliminating the 
background interacting proteins and identifying the specific interacting partners (Sowa et 
al., 2009). 
Using  the  IP-MS  approach,  we  identified  the  PAF1  transcription  elongation 
complex as an interacting partner of PHF6. The PAF1 complex has been established as 
the  RNA  polymerase  II  associated  complex  that  efficiently  promotes  transcriptional 
elongation. Originally identified in yeast, it has been shown to promote transcriptional 
elongation along the chromatin substrate in a variety of systems (Chen et al., 2009; Kim 
et  al.,  2010; Krogan et  al.,  2002;  Marton and  Desiderio,  2008; Rondon et  al.,  2004; 
Squazzo et al., 2002). It functions through a number of molecular mechanisms: 1) the 
PAF1  complex  can  directly  stimulate  RNA  polII  transcription  along  the  chromatin, 
through  physical  association  with  the  polymerase;  2)  the  PAF1  complex  acts 
synergistically  with  other  factors  that  promote  transcriptional  elongation,  such  as  the 
transcription  elongation  factor  SII;  3)  the  PAF1  complex  promotes  posttranslational 
modifications of the chromatin including H2B ubiquitination and H3K4/K79 methylation, 45 
 
which was suggested to facilitate future rounds of transcription at the modified genomic 
loci (Kim et al., 2010). 
Although the biochemical functions of the PAF1 complex has been studied quite 
extensively, its role in development and homeostasis remains very poorly characterized. 
Loss of Leo1, a critical component of the PAF1 complex, leads to defective development 
of  neural  crest-derived  cells  in  zebrafish  (Nguyen  et  al.,  2010),  whereas  mutation  of 
cdc73,  a  tumor  suppressor  gene,  is  directly  involved  in  predisposition  to 
Hyperparathyroidism-Jaw  tumor  syndrome  (HPT-JT)  and  in  development  of  some 
sporadic parathyroid tumors (Carpten et al., 2002). However, the biological functions of 
the PAF1 complex during brain development remain unstudied. I established a critical 
role of the PAF1 complex during neuronal migration in the mammalian cerebral cortex, 
thereby providing the first insight  into the role of PAF1 complex and transcriptional 
elongation in brain development. In addition, the identification of the PAF1 complex as a 
novel interacting complex for PHF6 provides important insights to the functions of PHF6 
and underlying mechanisms of BFLS pathophysiology. 
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Results 
Having established a critical role of PHF6 in the regulation of neuronal migration, 
I  next  determined the  mechanism by which PHF6 functions.  I first  characterized the 
subcellular  localization  of  PHF6.  I  found  that  PHF6  protein  was  localized  in  the 
nucleoplasm in primary cortical neurons, consistent with the possibility that PHF6 might 
regulate transcription (Figure 3-1A) (Lower et al., 2002). This immunopositive signal is 
likely to be specific because knockdown of PHF6 abrogates the signal (Figure 2-2 D and 
F). Similarly, ectopically expressed PHF6 localized to the nucleoplasm in 293T cells 
(Figure 3-1B). Since PHF6 is not known to harbor enzymatic activity, I reasoned that 
PHF6 might associate with other factors that in turn regulate transcription.  
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Figure 3-1. PHF6 is localized in the nucleus. (A) Immunocytochemical analyses of primary rat 
cortical neurons at DIV1 or DIV3 with the PHF6 and UBTF antibodies, the latter to label the 
nucleolus. PHF6 is localized in the nucleoplasm in neurons. DNA was stained with bisbenzimide 
in the right panel (in blue). (B) 293T cells stabling expressing HA-tagged PHF6 wildtype (WT) or 
different deletion mutants are subjected to immunocytochemical analyses using the HA antibody. 
PHF6 is localized in the nucleoplasm. Scale bar: 10m in (A) and (B). 
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To identify proteins that physically associate with PHF6, I used an approach of 
immunoprecipitation  followed  by  mass  spectrometry  (IP/MS).  I  used  a  rigorous 
proteomics method that compares a specific IP/MS dataset against a large set of unrelated 
parallel  IP/MS  datasets,  thus  distinguishing  high-confidence  candidate  interacting 
proteins (HCIPs) from background proteins (Behrends et al., 2010; Litterman et al., 2011; 
Sowa  et  al.,  2009).  I  infected  293T  cells  with  a  lentivirus  encoding  HA-PHF6,  and 
immunopurified  PHF6  from  cells  stably  expressing  HA-PHF6.  The  purified  PHF6 
immunoprecipitate was subjected to liquid chromatography–tandem mass spectrometry 
(LC-MS/MS)  analyses.  The  Comparative  Proteomics  Analysis  Software  Suite 
(CompPASS) platform was then used to identify HCIPs from greater than 500 proteins 
identified by LC-MS/MS (Sowa et al., 2009). Remarkably, all four core components of 
the  PAF1  transcription  elongation  complex,  PAF1,  LEO1,  CDC73  and  CTR9,  were 
found as robust HCIPs of PHF6 (Figure 3-2A).  
I validated the interaction of HA-PHF6 and the endogenous PAF1 complex in co-
immunoprecipitation analyses in 293T cells (Figure 3-2B). Importantly, I also found that 
endogenous PHF6 associated with all four components of the endogenous PAF1 complex 
in the cerebral cortex in mouse embryos at E17, an age that coincides temporally with 
migration of neurons to the superficial layers (Figure 3-2C). These data suggest that the 
PAF1 complex might represent a physiological interacting partner of PHF6. 
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Figure 3-2. PHF6 interacts with the PAF1 transcription elongation complex. (A) Lysates of 293T 
cells stably expressing N-terminally tagged HA-PHF6 were immunoprecipitated with the HA 
beads and  subjected  to  proteomic  analyses  using  LC-MS/MS.  Peptide  spectra  were  analyzed 
using the CompPASS software program to interrogate datasets against parallel IP/MS databases 
and assign scoring metrics. High-confidence candidate interacting proteins (HCIPs) of PHF6 are  50 
 
Figure 3-2. continued 
shown.  Rows  in  pink  denote  components  of  the  PAF1  complex.  (B)  Lysates  of  293T  cells 
expressing HA-PHF6 or HA-GFP were subjected to immunoprecipitation with the HA beads 
followed by immunoblotting with the HA, PAF1, LEO1, CDC73 and CTR9 antibodies. Input was 
also  immunoblotted  with  the  antibodies.  (C)  Lysates  of  E17  mouse  cerebral  cortex  were 
immunoprecipitated with the PHF6 antibody or rabbit IgG followed by immunoblotting with the 
PAF1, LEO1, CDC73, CTR9 and PHF6 antibodies. Asterisk denotes a non-specific band. Rabbit 
IgG signal from the PHF6 immunoblot is non-specific immunoreactivity from the rabbit heavy 
chain. 
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The PAF1 transcription elongation complex was originally identified in yeast as 
an  RNA  polymerase  II-associated  complex,  and  plays  a  critical  role  in  efficient 
transcriptional elongation along chromatin in yeast and mammalian cells (Marton and 
Desiderio, 2008; Rondon et al., 2004; Shi et al., 1996). The PAF1 complex has been 
implicated in tumorigenesis (Chaudhary et al., 2007; Lin et al., 2008; Newey et al., 2009). 
However, the role of the PAF1 complex in the brain has remained unexplored.  
To assess the role of the PAF1 complex in the developing mammalian brain, I 
first characterized the expression profile of the four components of the PAF1 complex 
during neuronal development. Interestingly, all four components were highly expressed 
during  early  neuronal  development  in  both  primary  cortical  neurons  and  the cerebral 
cortex in vivo (Figure 3-3A).  
I  next  asked  whether  the  PHF6-PAF1  interaction  is  functionally  relevant  in 
neuronal  migration.  I  reasoned  that  if  PHF6  acts  via  the  PAF1  complex  to  regulate 
neuronal  migration,  loss  of  PAF1  would  be  predicted  to  disrupt  neuronal  migration. 
Consistent  with  this  prediction,  knockdown  of  PAF1  by  two  distinct  shRNAs 
substantially  impaired  neuronal  migration  in  the  cerebral  cortex  in  vivo,  thus 
phenocopying  the  effect  of  PHF6  knockdown  (Figures  3-3B,  3-3C,  3-3D  and  3-3E). 
Collectively, these data suggest that PHF6 physically associates with the PAF1 complex 
and thereby drives neuronal migration. 52 
 
 
Figure 3-3. Downregulation of the PAF1 transcription elongation complex impairs neuronal 
migration in the cerebral cortex. (A) Lysates of primary rat cortical neurons or mouse cerebral 
cortex were immunoblotted with the PAF1, LEO1, CDC73, CTR9 and ERK antibodies. (B) 
Lysates of mouse cortical neurons infected with lentivirus expressing PAF1 shRNAs or control 
scrambled shRNAs were immunoblotted with the PAF1 and 14-3-3 antibodies. (C) Lysates of 
N2A cells infected with lentivirus expressing PAF1 shRNAs or control scrambled shRNAs were 
immunoblotted with the PAF1, LEO1, CDC73, CTR9 and 14-3-3 antibodies. (D) E14 mouse 
embryos were electroporated with an RNAi plasmid encoding PAF1 shRNAs or control 
scrambled shRNAs together with the GFP expression plasmid and allowed to develop until E19.  53 
 
Figure 3-3. continued 
The cerebral cortex from the E19 embryos was subjected to immunohistochemical analyses with 
the GFP antibody. PAF1 knockdown in the cerebral cortex in vivo profoundly impaired the radial 
migration of cortical neurons. (E) Quantification of the percentage of GFP positive neurons in 
distinct regions of the cerebral cortex in E19 mouse embryos treated as in (D) is presented as 
mean + SEM. PAF1 knockdown in the cerebral cortex in vivo significantly reduced the 
percentage of neurons that reached the upper cortical plate and concomitantly significantly 
increased the percentage of neurons stalled in the intermediate zone. Scale bar: 50m in (D). 
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Discussion 
In  contract  with  previous  studies,  I  find  that  PHF6  is  mostly  localized  in  the 
nucleoplasm, instead of the nucleolus, in immature neurons in vitro and in vivo, although 
in more mature neurons, there is some enrichment of PHF6 in the nucleolus. Several 
possibilities  would  explain  this  discrepancy:  1)  certain  studies  showed  the  nucleolar 
localization of overexpressed PHF6. Indeed, when I overexpressed PHF6 by transfecting 
GFP-tagged PHF6 into 293T cells or primary cultured cortical neurons,  I observed a 
strong nucleolar localization of GFP-PHF6. However, I think this reflects an abnormal 
localization of PHF6 due to an excessive expression level. This is further supported by 
the observation that when I expressed HA-PHF6 using lentivirus, which is thought to 
express  exogenous  proteins  at  a  lower  (and  probably  more  physiological)  level,  it  is 
localized  diffusely  in  the  nucleoplasm;  2)  PHF6  likely  localizes  to  different 
compartments  in  the  nucleus  in  different  cell  types,  and  probably  during  different 
developmental stages. Since knockdown of PHF6 largely abrogates the immunopositive 
signal in cortical neurons, I believe the nucleoplasmic localization is specific for PHF6. 
The identification of the PAF1 transcription elongation complex as an interacting 
partner of PHF6 implies a potential role of PHF6 in regulating transcription. PHF6 has 
long been speculated to play a role in transcription because it harbors two imperfect PHD 
finger domains. A lot of PHD finger domains recognize specific histone modifications 
and mediate downstream effects either through enzymatic function or through protein-
protein  interactions.  However,  our  preliminary  studies  failed  to  identify  any  histone 
marks that PHF6 recognizes. Therefore it remains unanswered whether PHF6 regulates 
transcription through interacting with histone marks, and thus it would be interesting to 
perform more detailed biochemical analysis to determine the molecular mechanisms of 
PHF6 function. 55 
 
The study of the PAF1 transcription elongation complex has mostly focused on its 
biochemical function in regulating transcription elongation. Previous in vitro and in vivo 
studies have established a role of the PAF1 complex in positively promoting transcription 
elongation along a chromatin template (Kim et al., 2010; Marton and Desiderio, 2008; 
Mueller et al., 2004; Squazzo et al., 2002). Yet the biological and cellular functions of the 
PAF1 complex remain largely unexplored. Our results reveal an essential role of the 
PAF1 complex in the regulation of neuronal migration, and potentially, the pathogenesis 
of X-linked intellectual disability.  
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Methods 
Plasmids 
The  shRNA  plasmid  targeting  sequences  are:  control: 
TACGCGCATAAGATTAGGGTA;  PAF1shRNA-1  (mouse): 
TATGACTATAAGATTGCTCGG;  PAF1shRNA-1  (rat): 
TATGACTACAAGATTGCTCGA;  PAF1shRNA-2  (mouse): 
TTGGTAGTGATGCTGATTCAG;  PAF1shRNA-2  (rat): 
TCGGTAGTGATGCTGATTCAG. Different shRNA targeting sequences were designed 
due to differences between mouse and rat coding sequences. 
 
Immunoprecipitation/mass spectrometry 
To identify specific PHF6 interactors, 293T cells stably expressing N-terminally 
HA-tagged PHF6 were generated using lentivirus followed by antibiotic selection. Four 
confluent 15cm dishes of stable PHF6-expressing cells were lysed in 0.5% Nonidet P40 
and subjected to immunoprecipitation using anti-HA resin (clone HA-7, Sigma). 
Immunoprecipitated PHF6 was eluted using HA peptide (Anaspec), and the eluted 
proteins were precipitated with trichloroacetic acid and digested with trypsin. The 
resulting tryptic peptides were desalted over C18 resin, and then loaded onto an LTQ 
linear ion trap mass spectrometer (Thermo Finnigan) for LC-MS/MS analyses. MS/MS 
spectra were searched using SEQUEST against a target-decoy database of tryptic 
peptides, and protein assignments were further deconvolved using the CompPASS 
software platform (Behrends et al., 2010; Litterman et al., 2011; Sowa et al., 2009). 
Using CompPASS, the uniqueness, abundance, and reproducibility of each protein 
assignment was compared across parallel sets of MS data generated from multiple 57 
 
unrelated immunoprecipitations to distinguish high-confidence protein interactors (HCIPs) 
from non-specific interacting proteins. HCIPs have WDN-scores >1.0. 
Immunoblotting 
Immunoblotting was performed as described (Lehtinen et al., 2006). The PAF1 
(Bethyl laboratories), LEO1 (Bethyl laboratories), CDC73 (Bethyl laboratories), and 
CTR9 (Bethyl laboratories) antibodies were used.58 
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Chapter 4 
 
 
The Neuroglycan C (NGC) gene is a key downstream target of 
PHF6 and PAF1 in the control of neuronal migration in vivo 
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Introduction 
In  the  previous  chapters,  I  uncovered  a  critical  function  of  the  PHF6-PAF1 
interacting  complex  in  the  regulation  of  neuronal  migration.  Knockdown  of  PAF1 
phenocopies PHF6 knockdown, suggesting that they act in a similar fashion to promote 
neuronal migration.  
The fact that PAF1 is positively involved in transcription elongation suggests that 
PHF6 might exert its function through regulation of transcription. Therefore an important 
remaining question is what are the downstream transcriptional events of PHF6 and PAF1.  
In  this  chapter,  I  characterize  the  downstream  events  of  PHF6  and  the  PAF1 
complex. I identify Neuroglycan C (NGC) as a critical downstream target of PHF6 and 
PAF1  complex,  and  NGC  mediates  their  effect  on  neuronal  migration.  Interestingly, 
NGC was identified as a potential susceptibility gene for schizophrenia. Therefore, my 
results suggest a potentially common basis of the underlying pathophysiology for BFLS 
and schizophrenia. 
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Results 
The finding that PHF6 interacts with the PAF1 transcription elongation complex 
and  thereby  promotes  neuronal  migration  in  the  cerebral  cortex  led  me  to  determine 
whether PHF6 exerts its function via regulation of gene expression. Because the PAF1 
complex promotes transcription, I reasoned that PHF6 might stimulate the expression of 
genes  that  mediate  neuronal  migration.  I  therefore  performed  microarray  analyses  of 
control and PHF6 knockdown primary cortical neurons. A large number of genes were 
downregulated in cortical neurons upon PHF6 knockdown (Table 4-1), consistent with 
the  conclusion  that  PHF6  regulates  gene  expression  in  neurons.  Among  the 
downregulated genes, several genes were found to encode proteins with potential roles in 
neuronal migration, including 14-3-3, Dync1i2, Ephb1, Abl1, Apbb2, Srgap3, Stmn1 
and Neuroglycan C (NGC). I validated the downregulation of selected genes in PHF6 
knockdown cortical neurons using two distinct PHF6 shRNAs. Among these genes, NGC 
was the most consistently and robustly downregulated gene in PHF6 knockdown neurons 
(Figure 4-1A and C). NGC was also robustly downregulated by PAF1 knockdown in 
primary cortical neurons, suggesting that NGC is coordinately regulated by PHF6 and the 
PAF1 transcription elongation complex (Figure 4-1B and D). 62 
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Table 4-1. continued 
Table 4-1. Microarray analyses of primary rat cortical neurons infected with lentivirus expressing 
PHF6  shRNAs  or  control  scrambled  shRNAs.  Selected  downregulated  genes  upon 
PHF6knockdown in cortical neurons are listed with fold change in their expression level. 
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Figure 4-1. Neuroglycan C (NGC) is a downstream target of PHF6 and PAF1 complex. (A) 
Quantitative RT-PCR analyses of primary rat cortical neurons infected with lentivirus expressing 
PHF6 shRNAs or control scrambled shRNAs. Levels of PHF6 and NGC were normalized to 
GAPDH levels (n=3). (B) Quantitative RT-PCR analyses of primary rat cortical neurons infected  65 
 
Figure 4-1. continued 
with lentivirus expressing PAF1 shRNAs or control scrambled shRNAs. Levels of PAF1 and 
NGC were normalized to GAPDH levels (n=3). (C) Quantitative RT-PCR analyses of primary 
mouse cortical neurons infected with lentivirus expressing PHF6 shRNAs or control scrambled 
shRNAs. Levels of PHF6 and NGC were normalized to GAPDH levels (n=3). (D) Quantitative 
RT-PCR analyses of primary mouse cortical neurons infected with lentivirus expressing PAF1 
shRNAs or control scrambled shRNAs. Levels of PAF1 and NGC were normalized to GAPDH 
levels (n=3). (E) In situ hybridization was performed on sections of E17 mouse cerebral cortex 
using probes for NGC. Sense probe was used as a negative control for the in situ hybridization. 
NGC is highly expressed in the VZ/SVZ and CP. Zoom in images of boxed regions are shown on 
the right. Scale bars in (E), 500m on the left, 100m on the right. 
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The NGC gene encodes a transmembrane chondroitin sulfate glycoprotein that is 
expressed  predominantly  in  the  brain  (Brandt  et  al.,  2007;  Kinugasa  et  al.,  2004; 
Nakanishi et al., 2006), and is a member of the neuregulin family of proteins, which is 
implicated in neuronal migration (Anton et al., 1997; Kinugasa et al., 2004; Rio et al., 
1997). However, NGC function in the brain has remained unknown. Interestingly, the 
NGC gene was recently identified as a potential susceptibility locus in schizophrenia, a 
neuropsychiatric  disorder  in  which  impaired  neuronal  migration  is  thought  to  play  a 
pathogenic role (Impagnatiello et al., 1998; Lee et al., 2011; So et al., 2010; Tomita et al., 
2011). Together, these observations raised the possibility that NGC might represent a 
physiologically relevant downstream target of the PHF6-PAF1 pathway in the control of 
neuronal migration. 
I assessed the role of NGC in neuronal migration. In utero knockdown of NGC in 
mouse embryos using two distinct shRNAs profoundly impaired neuronal migration in 
the cerebral cortex in vivo (Figures 4-2A, B and C). The extent of the migration defect 
correlated with the knockdown efficiency of NGC knockdown. Thus, NGC knockdown 
phenocopied the PHF6 knockdown phenotype. I next asked whether NGC mediates the 
ability  of  PHF6  to  drive  neuronal  migration.  Remarkably,  in  epistasis  analyses, 
expression of exogenous NGC in PHF6 knockdown animals largely restored the normal 
migration pattern in the cerebral cortex in vivo, suggesting that NGC represents a critical 
target of PHF6 in the control of neuronal migration (Figures 4-2D and E). Taken together, 
our data suggest that NGC mediates the ability of PHF6 to promote neuronal migration in 
the developing brain in vivo. 
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Figure 4-2. NGC is a key downstream target of PHF6 in the control of neuronal migration. (A) 
Lysates of 293T cells transfected with an expression vector encoding FLAG-NGC together with 
an RNAi plasmid encoding NGC shRNAs or control scrambled shRNA were immunoblotted 
with the FLAG and 14-3-3 antibodies. (B) Lysates of 293T cells transfected with an expression  68 
 
Figure 4-2. continued 
vector encoding FLAG-NGC wildtype (WT) or rescue (RES) together with an RNAi plasmid 
encoding NGC shRNAs or control scrambled shRNA were immunoblotted with the FLAG and 
14-3-3  antibodies.  (C)  E14  mouse  embryos  electroporated  with  an  RNAi plasmid  encoding 
NGC shRNAs or control scrambled shRNAs were allowed to develop until E19 and subjected to 
immunohistochemistry with the GFP antibody. NGC knockdown in the cerebral cortex in vivo 
profoundly impaired the radial migration of cortical neurons. (D) Quantification of the percentage 
of GFP positive neurons in distinct regions of the cerebral cortex in E19 mouse embryos treated 
as  in  (C)  is  presented  as  mean  +  SEM.  Knockdown  of  NGC  in  the  cerebral  cortex  in  vivo 
significantly  reduced  the  percentage  of  neurons  that  reached  the  upper  cortical  plate  and 
concomitantly  increased  the  percentage  of  neurons stalled  in  the  intermediate  zone.  (E)  E14 
mouse embryos electroporated with the NGC RNAi or control RNAi plasmid together with an 
expression  plasmid  enconding  NGC-Res  or  its  corresponding  control  vector were  allowed to 
develop until E19 and subjected to immunohistochemistry with the GFP antibody. Expression of 
NGC-Res suppressed the NGC knockdown-induced positioning defect in the cerebral cortex in 
vivo. (F) Quantification of the percentage of GFP positive neurons in distinct regions of the 
cerebral cortex in E19 mouse embryos treated as in (E) is presented as mean + SEM. Expression 
of NGC-Res significantly increased the percentage of neurons reaching the upper cortical plate in 
the background of NGC RNAi in the cerebral cortex in vivo (ANOVA, p<0.01). (G) E14 mouse 
embryos  electroporated  with  the  PHF6  RNAi  or  control  RNAi  plasmid  together  with  an 
expression plasmid enconding NGC or its corresponding control vector were allowed to develop 
until E19 and subjected to immunohistochemistry with the GFP antibody. Expression of NGC 
suppressed the PHF6 knockdown-induced positioning defect in the cerebral cortex in vivo. (H) 
Quantification of the percentage of GFP positive neurons in distinct regions of the cerebral cortex 
in  E19  mouse  embryos  treated  as in  (G) is  presented  as  mean  +  SEM.  Expression  of  NGC 
significantly increased the percentage of neurons reaching the upper cortical plate in the  
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Figure 4-2. continued 
background of PHF6 RNAi in the cerebral cortex in vivo (ANOVA, p<0.01). Scale bars: 50m in 
(C), (E) and (G).  70 
 
Discussion 
The identification of Neuroglycan C (NGC) as a target gene of PHF6 and PAF1 
that mediates PHF6-dependent migration has implications for the biology of both NGC 
and  PHF6.  PHF6  knockdown  induces  robust  downregulation  of  NGC,  and  NGC 
knockdown  phenocopies  PHF6  knockdown-induced  migration  arrest.  In  addition, 
expression of NGC largely compensates PHF6 knockdown-induced migration phenotype. 
Therefore NGC is a critical target of PHF6 in the pathogenesis of BFLS. In addition, 
since NGC has been implicated as a potential locus for schizophrenia (So et al., 2010), 
our  findings  raise  the  possibility  that  mutations  of  PHF6  may  contribute  to  the 
pathogenesis of neuropsychiatric disorders beyond intellectual disability. Conversely, it 
will  be  interesting  to  determine  whether  deregulation  of  NGC  might  play  a  role  in 
intellectual disability and epilepsy.  
How  does  NGC  regulate  neuronal  migration?  Given  that  NGC  is  a 
transmembrane molecule with a large ectodomain, NGC might act as a receptor or ligand 
that  mediates  cell-cell  interaction.  Indeed,  a  similar  mechanism  of  action  has  been 
reported for neuregulins in the cerebellar granule neurons, where neuronally expressed 
neuregulin acts on ErbB receptors on the radial glial fiber, and blocking the activation of 
ErbB4  on  the  radial  glia  impairs  neuronal  migration  (Rio  et  al.,  1997).  Therefore  I 
hypothesize that NGC probably mediates interaction between neurons and radial glia. In 
the future it will be interesting to identify the proteins that interact with NGC, with a 
particular  interest  on  the  ones  with  extracellular  domains,  which  might  mediate  this 
neuron-glia interaction.  
In addition to identifying the molecular mechanisms of BFLS pathophysiology, 
our results suggest that stimulating NGC expression or activity might confer a potential 
therapeutic benefit for BFLS. Because NGC is a transmembrane protein and a member of 
the neuregulin family (Kinugasa et al., 2004), NGC might represent an attractive target 71 
 
for  drug  development.  Thus,  in  addition  to  providing  insights  into  the  molecular 
pathogenesis of intellectual disability and potentially neuropsychiatric diseases, our study 
may provide novel molecular targets for future therapies for these devastating disorders.  
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Methods 
RT-PCR 
RT-PCR was performed as described (Yuan et al., 2008). Primers used for RT-
PCR  are:  PHF6  F:  GCGCAAATGTGGCTTTTGTA,  PHF6  R: 
TGCCTCTTTTAATTTCCTTTTGGA.  PAF1  F:  CATGACCTCCTGACTGAGCC, 
PAF1  R:  GCTTCTCATTGGAGATGCCA.  NGC  F:  ACACTCCCTGTGTCTCCTCC, 
NGC  R:  CAGGTCAGGTTATTCTGGAGACAG.  GAPDH  F: 
TGCTGGTGCTGAGTATGTCG, GAPDH R: GCATGTCAGATCCACAACGG. 
 
Plasmids 
The NGC expression plasmids were generated by PCR using mouse or rat cortical 
neuron  cDNA.  NGCshRNA-1:  TGGCTCACTATGATAACATTG;  NGCshRNA-2: 
TCCATGATAAGCCTAGTGTAG. 
 
In situ hybridization 
In  situ  hybridization  was  performed  using  coronal  cortical  sections  of  30-μm 
thickness,  prepared  from  E17  mouse  embryos.  The  full  length  cDNA  clone 
(NM_001166273, National Center for Biotechnology Information) was used for synthesis 
of digoxigenin (DIG)-labeled antisense and sense probes. Hybridization was carried out 
as described (Trimarchi et al., 2007). 73 
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The in situ hybridization was performed by Pamela Valnegri in our lab, with 
assistance of Sui Wang from the Cepko lab (Department of Genetics, Harvard Medical 
School).  
The remaining experiments described in this chapter were carried out by Chi 
Zhang. 
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Chapter 5 
 
 
PHF6 knockdown triggers the formation of white matter 
heterotopias with aberrant neuronal activity 
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Introduction 
In the previous chapters, I examined the molecular and cellular functions of PHF6 
during embryonic brain development. I identified the PHF6-PAF1-NGC transcriptional 
pathway that mediates its role in the regulation of neuronal migration. In this chapter, I 
extend our analysis to examine the broader question of how mutations of PHF6 would 
lead to cognitive dysfunction. 
Abnormal neuronal migration can impair cognitive functions in a number of ways. 
Most commonly, abnormal neuronal migration can present itself as ectopically located 
clusters of neurons below, within, or above the brain. For example, in females affected by 
the double cortex syndrome, ectopically located neurons form abnormal areas that appear 
as  band-like  clusters  of  cells  underneath  the  gray  tissue  of  the  cerebral  cortex 
(subcortical), creating the appearance of a double cortex (Gleeson et al., 1998). In the 
case  of  Cobblestone  lissencephaly,  overmigration  of  the  neuroblasts  and  glial  cells 
beyond the external glial limitations into the subarachnoid space leads to a nodular brain 
surface (Abdel Razek et al., 2009). Another possible scenario is that neuronal migration 
is not completely arrested but delayed. In this situation, there is unlikely to be dramatic 
changes  in  the  gross  brain  structure.  However,  since  the  establishment  of  synaptic 
connection is a highly coordinated process that requires a number of spatiotemporal cues, 
including both cell-autonomous and non cell-autonomous signals, a delay of neuronal 
migration might lead to changes in the environmental signals or responsiveness of the 
target cell, and thereby impairing the brain connectivity. Finally, it is becoming clear that 
the brain develops in a concerted manner where different cell types interact with each 
other, and abnormalities of one cell type can, in certain cases, lead to abnormalities of 
other cell types. For example, genetic manipulation of excitatory neurons, which induce 
the formation of heterotopic clusters of these neurons beneath the cortical plate, is able to 
recruit inhibitory neurons into the cluster, therefore resulting in further changes of brain 76 
 
connectivity (Lodato et al., 2011). Therefore, it would be important to understand how 
loss-of-PHF6 induced migration defect leads to cognitive impairment in BFLS patients. 
I  addressed  this  question  by  first  asking  whether  PHF6  induced  neuronal 
migration arrest is permanent or temporary. Intriguingly, PHF6 knockdown resulted in 
formation of subcortical heterotopia in postnatal brains, suggesting that loss of PHF6 
leads  to  permanent  changes  in  the  brain  structure.  Interestingly,  electrophysiological 
recordings  revealed  remarkable  hyperexcitability  of  heterotopic  neurons,  which  is 
potentially  relevant  to  the  elevated  seizure  susceptibility  observed  in  BFLS  patients. 
Therefore,  our  results  provided  a  potential  explanation  for  the  cognitive  dysfunction 
induced by PHF6 mutation.   77 
 
Results 
Having elucidated a mechanism by which PHF6 orchestrates neuronal migration 
in  the  developing  cerebral  cortex  in  vivo,  I  next  turned  my  attention  to  the  broader 
question of how loss of PHF6 might contribute to disease pathogenesis in BFLS. I first 
asked whether PHF6 knockdown simply delays neuronal migration during development 
or  whether  consequences  of  impaired  migration  persist  beyond  the  formation  of  the 
cerebral  cortex.  To  address  this  question,  I  electroporated  E14  mouse  embryos  and 
allowed  embryos  to  develop  past  birth  until  postnatal  day  6  (P6).  In  these  analyses, 
almost  all  transfected  neurons  in  control  animals  were  found  in  layers  II-IV  and 
expressed Cux1, a marker of superficial layer neurons (Nieto et al., 2004). Strikingly, 
neurons in PHF6 knockdown animals failed to reach the superficial layers in mouse pups 
at P6. Rather, they formed subcortical heterotopias in the white matter and were also 
found ectopically in layers V-VI. Quantification revealed that 98% of Cux1 positive, 
transfected cortical neurons reached layers II-IV in control animals, whereas only 32% of 
Cux1 positive, transfected neurons reached the superficial layers in PHF6 knockdown 
animals  (Figures  5-1A  and 5-1B). The failure  of PHF6 knockdown neurons  to  reach 
layers  II-IV  in  P6  animals  was  not  due  to  impaired  neuronal  differentiation,  as  the 
heterotopic neurons expressed Cux1 but not Ctip2, a marker for layer V neurons (Figure 
5-1C, 5-1D and 5-1E). These data suggest that loss of PHF6 triggers the formation of 
heterotopia in the cerebral cortex in vivo.  
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Figure 5-1. PHF6 knockdown leads to heterotopia formation in the postnatal brains. (A) E14 
mouse embryos were electroporated with the RNAi plasmid encoding PHF6 shRNAs or control 
scrambled shRNAs together with the GFP expression plasmid and allowed to develop until P6. 
The cerebral cortex from the P6 mouse pups was subjected to immunohistochemical analyses 
with the GFP and Cux1 antibodies. Arrowheads denote heterotopic neurons in PHF6 knockdown  79 
 
Figure 5-1. continued 
animals. WM, white matter. (B) Quantification of the percentage of GFP positive, Cux1 positive 
neurons in distinct regions of the cerebral cortex in P6 mouse pups treated as in (A) is presented 
as mean + SEM. PHF6 knockdown significantly increased the percentage of GFP positive, Cux1 
positive neurons in the white matter in vivo. (C) Representative image of heterotopic neurons in 
the  white  matter  in  PHF6  knockdown  animals.  GFP  positive  neurons  are  positive  for  Cux1 
(arrows). (D) E14 mouse embryos were treated the same way as in (A) and the cerebral cortex of 
P6 animals were subjected to immunohistochemistry with the GFP and Ctip2 antibodies. (E) 
Representative image of heterotopic neurons in the white matter in PHF6 knockdown animals. 
GFP positive neurons are negative for Ctip2 (arrowheads). Scale bars: 100m in (A) and (D), 
30m in (C) and (E).  
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We next examined the electrophysiological properties of transfected neurons in 
the  electroporated  animals.  Whole-cell  patch  clamp  recordings  were  performed  using 
acute  cortical  slices  prepared  from  P10  control  or  PHF6  knockdown  animals.  Under 
current  clamp  configuration,  we  observed  an  aberrant  pattern  of  activity  in  70%  of 
heterotopic neurons (9 out of 13 cells recorded), but not in neurons that reached layers II-
IV, in PHF6 knockdown animals (Figure 5-2A). The membrane potential of heterotopic 
neurons oscillated, leading to frequent firing of action potentials (Figure 5-2A). In other 
analyses, spontaneous excitatory postsynaptic currents (sEPSCs) were observed in layer 
II-IV neurons from control or PHF6 knockdown animals but not in heterotopic neurons 
from PHF6 knockdown animals, suggesting that the membrane potential of heterotopic 
neurons oscillated spontaneously in the absence of synaptic inputs (Figures 5-2C, 5-2D 
and 5-2E). The membrane potential oscillation in heterotopic neurons was blocked by 
nimodipine,  which  inhibits  L-type  voltage  gated  calcium  channels,  suggesting  that 
calcium  currents  might  underlie  the  spontaneous  depolarization  (Figure  5-2B). 
Interestingly, knockdown of NGC leads to formation of heterotopia that harbors a similar 
pattern of neuronal activity (Figure 5-2F). Together, these data suggest that inhibition of 
the  PHF6  pathway  triggers  the  formation  of  heterotopias  in  which  neurons  are 
hyperexcitable.    81 
 
Figure 5-2. PHF6 knockdown induces ectopic neuronal activity in the heterotopic neurons. (A)  82 
 
Figure 5-2. continued 
E14 mouse embryos were electroporated with the RNAi plasmid encoding PHF6 shRNAs or 
control scrambled shRNAs together with the GFP expression plasmid and allowed to develop 
until P10. Representative images for whole-cell recordings in current  clamp of GFP positive 
neuron  in  cortical  slices  from  P10  PHF6  knockdown  or  control  mouse  pups  are  shown. 
Heterotopic neurons in P10 PHF6 knockdown animals exhibit aberrant neuronal activity. (B) 
Representative images for whole-cell recordings in current clamp of GFP positive heterotopic 
neurons in cortical slices from P10 PHF6 knockdown mouse pups are shown. Abnormal firing 
patterns of heterotopic neurons are blocked by bath application of 10M nimodipine. Left and 
right panels are recordings from the same neuron before and after adding the inhibitor.  (C-E) 
Representative  images  for  whole-cell  patch  clamp  recordings  of  spontaneous  EPSCs  under 
voltage clamp configuration of GFP positive neurons in cortical slices from P10 control (C) or 
PHF6  knockdown  (D  and  E)  mouse  pups  are  shown.  Neurons  were  held  at  their  resting 
membrane  potentials  during  sEPSC  recordings.  Heterotopic  neurons  do  not  exhibit  synaptic 
current input. The two heterotopic neurons are the same neurons shown in (A). (F) E14 mouse 
embryos  were  electroporated  with  the  RNAi  plasmid  encoding  NGC  shRNAs  with  the  GFP 
expression plasmid and analyzed as in (A). Heterotopic neurons in P10 NGC knockdown animals 
exhibit aberrant neuronal activity. 
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Discussion 
The finding that loss of PHF6 induced migration arrest leads to heterotopia 
formation has important implications in the pathogenesis of BFLS. Clinically, heterotopia 
formation is highly associated with epileptic activity of the brain, which has been 
documented in certain BFLS patients (Robinson et al., 1983). Additionally, the 
heterotopic neurons are hyperexcitable, even without any synaptic current input. This 
raises the possibility that hyperexcitability of heterotopic neurons will increase the 
overall excitability of the brain and therefore, render the entire brain more susceptible to 
epileptic stimulus.  
Heterotopia formation has been postulated to contribute to elevated seizure 
susceptibility via a number of means. One the one hand, heterotopia may by itself serve 
as the loci that initiates the seizure activity. Clinical evidence using depth electrode 
recordings or stereoencephalography (SEEG) recordings in patients support the idea that 
heterotopic loci plays a role in the generation of the epileptic activity, although it remains 
controversial whether the heterotopia is the initiator or propagator of seizure activity 
(Aghakhani et al., 2005; Kothare et al., 1998). Work with animal models also suggests a 
critical role of heterotopia in epileptogenesis (Ackman et al., 2009; Manent et al., 2009). 
Animals with genetically induced or chemically induced heterotopia show spontaneous 
epilepsy or reduced threshold for seizure induction. Notably, heterotopic neurons are 
often found to connect to diverse regions of the brain, and occasionally even outside the 
brain. For example, retrograde labeling experiments show connection of heterotopic 
neurons to the spinal cord and thalamus in the tish (telencephalic internal structural 
heterotopia) model (Lee et al., 1997). Additionally, heterotopic neurons participate in the 
whole neuronal network, and exhibit network-driven bursts of activity (Smith et al., 
1999). Therefore, it is likely that heterotopic neurons, induced by loss of PHF6, are able 84 
 
to transmit their ectopic activity pattern to the various parts of the brain through their 
synaptic connections.  
Is heterotopia formation and associated susceptibility relevant to BFLS? It is 
unfortunate that detailed pathological studies of the BFLS brains are missing or very 
incomplete. Over the course of this study I obtained an MRI scan of a female BFLS 
patient whose genetic studies suggested a deletion of PHF6. However, we were unable to 
identify heterotopia within her brain, at least on a macroscopic level as MRI offers. 
Although this remains inconclusive, it is possible that heterotopia formation represents a 
more acute outcome of neuronal migration arrest, presumably due to the more acute 
effect of RNAi-mediated knockdown, whereas in patient brains, point mutation or 
truncation of PHF6 leads to partial loss-of-function, resulting in a milder migration arrest. 
In addition, compared to other disorders of neuronal migration such as the double cortex 
syndrome, the degree of intellectual disability is in general milder in BFLS: DCX 
mutation in males leads to prenatal lethality, and only female patients survive and exhibit 
intellectual disability, whereas BFLS predominantly affects males and female carries are 
mostly normal or affected very mildly. Therefore, the degree of brain malformation is 
likely lower in BFLS than other disorders such as double cortex syndrome.  
Nevertheless, an earlier post-mortem pathology study in a patient suffering from 
severe intellectual disability revealed a brain structure with clear signs of widespread 
neuronal migration defect, including a coarse gyri, cortical dysplasia with large areas of 
indistinct or absent lamination, presence of excessive numbers of neurons or solid 
heterotopic grey matter in the subcortical white matter (Brun et al., 1974). All of these 
findings are highly consistent with my findings in the embryonic mouse brain, suggesting 
a critical pathophysiological relevance of our study. Thus, it will be important for future 
studies to perform detailed brain imaging and examine evidence of heterotopia in BFLS 
brains. 85 
 
Collectively, I have identified a novel transcriptional pathway whereby the X-
linked intellectual disability protein PHF6 forms a complex with the PAF1 transcription 
elongation complex and thereby induces the expression of NGC, leading to the migration 
of  cortical  neurons  in  the  cerebral  cortex.  Deregulation  of  this  novel  transcriptional 
pathway may play a critical role in the pathogenesis of intellectual disability and epilepsy 
in the X-linked disorder BFLS. 
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Methods 
Electrophysiology 
Acute cortical slices (350m) were prepared from the cerebral cortex of P10-P12 
mice by vibratome (Leica VT1000s). After one hour recovery at 37° C , slices were 
maintained in a storage chamber containing ASCF (124mM NaCl, 5mM KCl, 1.25mM 
NaH2PO4, 1.3mM MgCl2, 2.6mM CaCl2, 26mM NaHCO3, and 15mM D-Glucose, pH 7.4, 
310 mOsM) gassed with 95% O2/ 5% CO2 at room temperature. Whole-cell patch-clamp 
recordings were performed in cortical pyramidal neurons. Recording electrodes (3-5MΩ) 
were filled with intracellular solution containing: 110mM K gluconate, 20mM KCl, 5mM 
MgCl2, 20mM HEPES, 0.2mM EGTA, 2mM MgATP, 0.3mM Na3GTP, pH 7.3, 300 
mOsm. Electrophysiological signals were acquired by Axon-700B multiclamp amplifier, 
digitized at 10 kHz by a Digidata 1440A D-A converter and Bessel filtered at 1kHz. For 
current clamp recording of GFP-positive heterotopic neurons from PHF6 knockdown 
animals, the membrane potential was held at -55mV in current clamp by injecting 
hyperpolarizing current (5 to 10pA). 87 
 
Attributions 
 
All electrophysiological recordings were performed by Ju Huang in the Bonni lab. 
The remaining experiments described in this chapter were carried out by Chi 
Zhang. 
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Chapter 6 
Perspectives 
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Using RNAi-mediated knockdown in in vivo mouse models, I identified abnormal 
neuronal migration as the critical pathophysiological basis for intellectual disability in 
BFLS. I linked this function of PHF6 to regulation of transcription through identifying 
the PAF1 transcription elongation complex as an interacting partner, and NGC as a key 
downstream target. This study revealed important aspects of developmental neurobiology, 
and has broad implications in many fields of biology. Here I highlight a few exciting new 
areas that this study has opened up. 
Important role of transcriptional elongation in neuronal development 
Traditionally, transcriptional elongation has long been viewed as a passive, 
unregulated stage where polymerase II passes through the DNA spontaneously. A lot of 
studies have focused on regulation of transcriptional initiation and thus, ignored the 
importance of elongation during the transcription cycle. 
However, this view is being challenged by recent findings that elongation is a 
heavily regulated process and is intimately linked to the transcription cycle. Seminal 
findings using drosophila and human cells identified paused RNA polII at the promoter 
region, and more importantly, these polII are transcriptionally engaged and have formed a 
nascent RNA chain of ~25 nucleotides (Bentley and Groudine, 1986; Rougvie and Lis, 
1988). This finding was corroborated by numerous studies using a variety of modern 
techniques, and the emerging view is that nascent transcriptional initiation is wide spread 
along the genome, and the transition from initiating to elongating phase of transcription 
represents a critical step of regulation (Guenther et al., 2007; Krumm et al., 1995; Muse 
et al., 2007; Nechaev and Adelman, 2011) 90 
 
 The PAF1 transcription elongation complex plays critical roles in promoting 
transcription elongation along the chromatin template. Work from laboratories of Robert 
G. Roeder, Danny Reinberg and Hiroshi Handa, among others, have firmly established 
that the PAF1 complex cooperates with other factors, including DSIF and the elongation 
factor SII/TFIIS, and promotes elongation of polII along the gene body (Chen et al., 2009; 
Kim et al., 2010; Zhu et al., 2005).  
My study highlights the first biological function of the PAF1 complex in the 
nervous system, and suggests that regulation of transcriptional elongation is a critical step 
of control in neuronal migration. Therefore, it opened up a new area of exciting 
possibilities for future studies. Potential remaining questions include: 
1.  How does PAF1 regulate NGC levels? 
In my study, we performed RT-PCR analysis and observed a reduction of NGC 
levels upon knockdown of PAF1. Since the PAF1 complex positively regulates 
transcriptional elongation, an immediate hypothesis is that PAF1 complex regulates NGC 
levels through positively promoting transcriptional elongation at the genomic loci.  
I performed preliminary CHIP (chromatin IP) experiment to examine the 
distribution of RNA polII, PAF1 complex on the NGC genomic loci. Unfortunately, I 
was unable to detect any significant enrichment of these factors along the NGC loci, 
although it is important to point out that this assay is limited by the detection sensitivity 
of quantitative PCR. Also, it is well documented in the literature that it is difficult to 
detect significant enrichment of polII and other polII associated factors under basal levels 
of transcription (Chen et al., 2009). Therefore, even the preliminary result is negative, it 91 
 
is possible that at basal level, PAF1 complex and polII is present at a low level that is 
beyond the detection limit. 
Nevertheless, I successfully performed CHIP experiments to examine the status of 
post-translational modifications on histones in the NGC genomic loci. The underlying 
rationale is that PAF1 complex was shown to be critical for modifications of histones, 
such as H3K4 tri-methylation (H3K4me3) or ubiquitination of histone H2B (ubH2B) 
(Krogan et al., 2003; Wood et al., 2003). Therefore the hypothesis is that PHF6 may 
promote modifications of histones along the NGC genomic loci through interactions with 
the PAF1 compex. I was able to detect specific H3K4me3 and ubH2B signal along the 
NGC loci, yet knockdown of PHF6 did not change the modification status of H3K4me3 
or ubH2B, even though in the same experiments PHF6 knockdown led to a decrease of 
NGC RNA levels. This data argues against the hypothesis that changes in the 
modification status of histones are the underlying causes for a reduction of NGC RNA 
levels. It remains to be determined whether PAF1 knockdown leads to a change of the 
modification status along the NGC loci.  
2.  What are the additional targets and functions of PAF1 in neuronal 
development? 
Given the ubiquitous role of transcriptional elongation in gene regulation, it is 
very likely that the PAF1 complex is involved in the regulation of other biological 
processes in neuronal development and homeostasis through regulation of additional 
targets. Therefore it will be interesting to perform genome wide studies to identify 92 
 
additional targets of the PAF1 complex in the nervous system, which hopefully will lead 
to new findings of PAF1 function in the brain. 
 
What is the biochemical function of PHF6 
In my study, I established a physical interaction of PHF6 and the PAF1 
transcription elongation complex. However, an important question that follows is what is 
the biochemical function of PHF6, and how it exerts its function. 
Given the interaction between PHF6 and the PAF1 complex, one immediate 
hypothesis is that PHF6 might be somehow related to the function of PAF1 complex. To 
test this hypothesis, I adopted an activity-induced transcription assay as a readout of 
PAF1 function. It is already known that EGF induced expression of the immediate early 
gene c-fos in Hela cells is dependent on the PAF1 complex and efficient transcriptional 
elongation. Therefore, by examining the temporal dynamics of c-fos induction upon 
PHF6 knockdown, I can determine whether PHF6 is required for PAF1 function in this 
paradigm.  
My preliminary results seemed to suggest that PHF6 is not required for c-fos 
induction under this experimental paradigm (Figure 6-1). Knockdown of PHF6 did not 
significantly impair induction of c-fos as PAF1 knockdown did. It would be important to 
repeat this experiment in the future to validate the result.  93 
 
 
Figure 6-1. Preliminary data on the effect of PHF6 knockdown on EGF induced c-fos expression 
in Hela cells. PHF6 knockdown does not have a significant effect on c-fos induction whereas 
PAF1 knockdown blunts the induction of c-fos. 
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On the other hand, it is necessary to perform more detailed biochemical studies 
for PHF6. Important remaining questions include:  
1.  Does PHF6 interact with DNA or does it interact with histones, or even 
other molecules such as RNA? 
2.  What determines the specificity of regulation by PHF6? 
The answer to these questions will add important insights to the understanding of 
how PHF6 functions in normal development. 
 
Implications on cancer biology 
Both PHF6 and the PAF1 complex were found to be involved in the development 
of leukemia. In particular, PHF6 mutations were identified in T-cell acute lymphoblastic 
leukemia (T-ALL), an aggressive form of hematological malignancy that has a high 
incidence in males (Van Vlierberghe et al., 2010). Somatic missense or truncating 
mutations of PHF6 were identified in T-ALL patients, suggesting that loss of PHF6 might 
play a critical role in the pathogenesis of T-ALL.  
The PAF1 complex was found to interact with the MLL, translocations of which 
create potent oncogenic fusion proteins that account for the majority of infant acute 
leukemias. The PAF1 complex is required for MLL fusion protein mediated 
transcriptional activation and recruitment of MLL to target genes, therefore plays a 
critical role in the initiation of leukemia (Muntean et al., 2010).  95 
 
The fact that both PHF6 and PAF1 complex are linked to the formation of 
leukemia raises the intriguing possibility that our study has important implications on 
cancer biology. Interesting questions to address include the followings: 
1.  Whether PHF6 and PAF1 complex interact in leukemia cells? 
Although we validated the PHF6-PAF1 interaction in 293T cells, it is important to 
validate this in a relevant system, such as the Jurkat cells. 
2.  What are the physiological consequences upon loss of PHF6 in leukemia 
cells? 
In view of the mutational loss of PHF6 in T-ALL, it would be important to 
perform functional studies of PHF6 in the formation of leukemia.  
 
Functional consequence of ectopic neuronal activity on brain function 
We have identified that PHF6 knockdown leads to heterotopia formation in the 
postnatal brain, which harbors ectopic neuronal activities. Therefore an important 
question remains as to what are the physiological consequences of having these 
heterotopic neurons in the otherwise normal brain. 
Previous work from Alfonso Represa’s group has shown that genetic knockdown 
rat models of human double cortex syndrome presented spontaneous seizure activity after 
adulthood (Lee et al., 1997; Manent et al., 2009). This raised the interesting possibility 
that PHF6 knockdown induced heterotopia formation might have similar effects on the 
overall brain activity.  96 
 
To start testing this possibility, I performed some preliminary behavioral 
experiment where I injected the convulsant pentylenetetrazol (PTZ) to induce seizure 
activity in control or PHF6shRNA electroporated animals and examine the threshold for 
seizure. I did not observe any obvious differences in the threshold to PTZ-induced seizure. 
However, this is a rather crude experiment and might not allow detection of more minor 
differences in sensitivity to seizure. In the future, EEG recordings on the electroporated 
animals would be helpful in determining whether these animals suffer from spontaneous 
seizure activity.  
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PHF6 is a potential substrate for the protein kinase Cdk5 
Introduction 
Having established a critical function of PHF6 in neuronal migration, I then 
considered potential regulators of PHF6 function. Protein phosphorylation is a common 
form of post-translational modification that impacts protein functions in a number of 
different ways, and is found to regulate multiple biological processes including neuronal 
migration. Therefore I considered the possibility that PHF6 might be subject to regulation 
through events such as phosphorylation. 
A scan of the amino acid sequences of PHF6 revealed a few potential 
phosphorylation sites on PHF6, including potential sites for Abl kinase, PKC epsilon, 
ATM and Cdk kinases (http://scansite.mit.edu/). The potential phosphorylation sites for 
Cdk kinases are particularly interesting. This is because Cdk5, one of the Cdk family 
members, is highly implicated in neuronal morphogenesis, and in particular, regulation of 
neuronal migration. Knockout of Cdk5 leads to an inverted cerebral cortex where the 
brain loses the appropriate lamination pattern (Chae et al., 1997; Jin et al., 2010). A 
number of substrates have been identified that mediates its function in cell adhesion and 
neuronal migration, including PAK1, Tau, MAP1B and DCX ect (Dhavan and Tsai, 2001; 
Tanaka et al., 2004). Therefore, I think Cdk5 might be an interesting candidate kinase to 
examine that regulates PHF6 through phosphorylation. 
I first examined the potential sites of phosphorylation on PHF6. Interestingly, out 
of the potential Cdk sites on the PHF6 protein, serine199 is highly conserved across the 
different species. Importantly, the +1 and +3 positions are also very conserved, and fits 99 
 
really well for the consensus Cdk5 site (S/T)PX(K/H/R) (Figure S1). Therefore, I focused 
on our study on this site. 
 
Figure S1. Alignment of PHF6 protein sequences cross different species around the consensus 
Cdk5 phosphorylation site. The serine residue is underlined, and the proline and arginine residues 
are highlighted in red to indicate that this is a conserved Cdk consensus site. 
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To examine the potential phosphorylation, I first performed in vitro kinase assay 
to test whether Cdk5 phosphorylates PHF6 in vitro. Incubation of recombinant PHF6 
together with wildtype (WT) Cdk5 leads to robust phosphorylation of PHF6 assayed by 
incorporation of P
32. Importantly, incubation with kinase dead (KD) Cdk5 failed to 
phosphorylate PHF6 (Figure S2A), suggesting that the phosphorylation event is likely to 
be due to the presence of Cdk5 but not contaminating proteins in the immunoprecipitate.  
I next asked whether the serine199 residue is the principle phosphorylation site on 
PHF6. To address this question, I mutated the serine residue to alanine, and subjected the 
recombinant protein to in vitro kinase assay. Interestingly, mutation of Ser199 strongly 
reduced the amount of phosphorylation on PHF6 by Cdk5 (Figure S2B), suggesting that 
this serine residue is the major site of phosphorylation by Cdk5. 
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Figure S2. Cdk5 phosphorylates PHF6 in vitro on the Ser199 residue. (A) HA-Cdk5 
immunoprecipitated from 293T cells are subjected to in vitro kinase assay with radioactive p
32-
ATP and either GST or GST-PHF6 protein purified from E. coli. The upper panel shows 
radioactive signal, middle panel showing coomassie staining of the gel and the lower panel shows 
western blotting of HA tag. (B) in vitro kinase assay was performed as in (A) using either 
wildtype (WT) or S199A mutant GST-PHF6. Mutation of this serine residue significantly impairs 
the phosphorylation of PHF6 by Cdk5. 
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For future studies, it would be important to answer the following questions: 1) is 
PHF6 phosphorylated by Cdk5 in cells? 2) If PHF6 is indeed phosphorylated by Cdk5, 
what is the biological function of this phosphorylation? I have performed preliminary 
experiments examining the effect of the S199A mutant on neuronal migration. My 
preliminary data suggest that the S199A mutant is not as effective as the WT protein in 
promoting neuronal migration, although this result needs further validation. 3) Under 
what circumstances does Cdk5 phosphorylate PHF6? Since Cdk5 and PHF6 are both 
required for neuronal migration, one hypothesis would be that Cdk5 phosphorylation of 
PHF6 promotes its function of promoting neuronal migration. 
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PHF6 might control additional stages of neuronal maturation 
In PHF6 knockdown animals, we examined the electrophysiological properties of 
GFP positive neurons that have reached layers II-IV, the proper location for that cohort of 
neurons. Interestingly, we observed a strong reduction of the frequency, but not much so 
for amplitude, for spontaneous excitatory postsynaptic current (sEPSC) (Figure S3A). 
Quantification revealed that frequency of sEPSC reduced more than 2 fold by PHF6 
knockdown, whereas the amplitude of sEPSC in PHF6 knockdown neurons is only 
modestly lower than control neurons (Figure S3B, S3C, S3D and S3E).  
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Figure S3. Knockdown of PHF6 reduces frequency of sEPSC in layer II-IV neurons. (A) 
Representative traces of sEPSC recorded in GFP positive, layer II-IV neurons in P10  105 
 
Figure S3. continued 
electroporated animals. PHF6 RNAi reduces the frequency of sEPSC in layer II-IV neurons. (B-C) 
Quantification of sEPSC frequency (B) and amplitude (C) of GFP positive layer II-IV neurons. 
PHF6 knockdown significantly reduced the frequency but not amplitude of sEPSCs. (D-E) 
Cumulative plot of sEPSC frequency (D) and amplitude (E) in GFP positive layer II-IV neurons.  
   106 
 
To further validate this result, additional experiments, including testing an 
additional shRNA, will be needed.  
The observation that knockdown of PHF6 leads to a reduction of sEPSC might be 
due to a few reasons. 1) PHF6 might have a function in neuronal development and 
maturation post-migration. Indeed, I observed that in P6 brains, knockdown of PHF6 by 
shRNA-2 in layer II-IV neurons lead to a reduction of dendritic complexity (Figure S4). 
Defects of post-synaptic development are also possible although I did not examine that 
possibility. 2) this reduction of spontaneous synaptic event is secondary to delayed 
neuronal migration. Establishment of neuronal connectivity is a spatiotemporally 
restricted process and a number of intrinsic and extrinsic cues come into play when 
synaptic connections are being established. Therefore it is possible that loss of PHF6 
induced neuronal migration causes a delayed positioning of the neurons in the correct 
layer, therefore impairing the synaptic connections.  
To test these possibilities, it would be interesting to use in vitro hippocampal 
neuron culture to ask whether PHF6 is required for dendritic complexity and post-
synaptic development. Also this system would allow examination of synaptic connection 
without the confounding issue of neuronal migration. In addition, lentivirus injection into 
postnatal brains can also help us eliminate the confounding possibility that the reduction 
in sEPSC frequency is secondary to delayed neuronal migration, in an in vivo setting.  
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Figure S4. PHF6 knockdown reduces dendritic complexity in layer II-IV neurons. Animals were 
electroporated at E14 and brains were harvested at P6 followed by immunohistochemical analysis 
with the GFP antibody. Knockdown of PHF6 severely impaired the normal dendritic complexity 
of layer II-IV neurons. 
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I also explored other biological functions of PHF6. Especially, from the 
microarray, I observed that a number of molecules critical for establishing neuronal 
connectivity were downregulated by PHF6 knockdown. In particular, I was able to 
validate that EphB1 is likely to be an interesting downstream target of PHF6. Two 
shRNAs against PHF6 similarly lead to a downregulation of EphB1 (Figure S5), 
suggesting that it is likely a real downstream target for PHF6.  
EphB1 is an interesting candidate for the study of neurobiology. It has been linked 
to multiple processes during neural development including axonal outgrowth, pathfinding, 
synaptic maturation and plasticity and neuronal apoptosis (Bilimoria et al., 2010; 
Depaepe et al., 2005; Gao et al., 1999). Therefore, it is possible that PHF6 also controls 
these biological processes through the regulation of EphB1 abundance, and thus, it 
remains interesting to test the role of PHF6 in these biological processes. 
 
Figure S5. RT-PCR analysis of primary cultured rat cortical neurons infected with lentivirus 
expressing PHF6 shRNAs at DIV0 and harvested at DIV5. Levels of PHF6 and EphB1 were 
normalized by GAPDH. Knockdown of PHF6 by two independent shRNAs significantly reduced 
EphB1 levels. 
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FoxA family members are potential substrates for MST1, a protein kinase 
involved in apoptosis signaling 
MST1 is a kinase that is implicated in regulation of apoptosis. Previously, our 
laboratory has identified that MST1 is critically involved in the process of oxidative 
stress induced neuronal cell death, and functions through phosphorylating the FOXO 
family members that in turn, promote transcription of downstream pro-apoptotic targets 
such as BIM (Lehtinen et al., 2006). To advance our understanding of the MST1 
signaling pathway, I carried out both candidate studies and unbiased studies to identify 
novel substrates for MST1. 
MST1 phosphorylates FOXO3 at Serine 207, a residue within the forkhead 
domain that is highly conserved in the forkhead family members. Therefore I searched 
for additional forkhead family members to see if any interesting candidates might be 
subject to regulation by MST1. In addition, the lab has established that the MST1-FOXO 
signaling pathway promotes longevity in C. elegans, and overexpression of the MST1 
homolog cst-1 extends lifespan in a daf-16 dependent manner. Therefore, I searched for 
an additional downstream target that might link MST1 and longevity. 
FoxA family members turn out to be very interesting candidates because recent 
studies show that it is essential for diet restriction induced longevity in C. elegans 
(Panowski et al., 2007). The potential MST1 phosphorylation site is highly conserved in 
FoxA family members, therefore they might be novel targets of MST1 (Figure S6). 
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Figure S6. Alignment of FoxA family members with FoxO3, highlighting the conservation of the 
potential MST1 phosphorylation site.  
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To test whether MST1 phosphorylates FoxA, I performed in vitro kinase assay 
using MST1 purified from 293T cells and GST-FoxA1/2 produced from E.coli. 
Interestingly, MST1 phoshorylates the forkhead domain of FoxA1/2 in vitro (Figure S7), 
suggesting that FoxA family members  might be novel substrates of MST1. In addition, 
polyclonal antibodies raised against phospho-Ser205 reside on FoxA1 also confirmed that 
this residue is indeed phosphorylated by MST1 in vitro (Figure S8). 
Additional questions remain regarding the phosphorylation event. For example, 
does the phosphorylation happen in cells? What is the physiological function and 
relevance of this modification?  
 
Figure S7. Cdk5 phosphorylates PHF6 in vitro on the Ser199 residue. Flag-MST1 
immunoprecipitated from 293T cells are subjected to in vitro kinase assay with radioactive p
32-
ATP and either GST or GST-FoxA1/2 or GST-FoxO1 purified from E. coli. The two different 
panels show two exposures of the film, with the lower panel showing a longer exposure. 112 
 
                                    
 
Figure S8. MST1 phosphorylates FoxA family members at the conserved Ser206 site. In vitro 
kinase assay was performed with Flag-MST1 and recombinant GST-Forkhead FoxA2 using cold 
ATP. The reaction is then subjected to immunoblotting using GST, Flag or an antibody directed 
at  phosphorylated  Ser206  site  of  FoxA2.  Wildtype  (WT)  but  not  kinase  dead  (KD)  MST1 
phosphorylates FoxA2 at Ser206 site. 
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Unbiased screen to search for MST1 consensus phosphorylation site 
In order to better understand MST1 functions, I sought to better characterize a 
consensus motif for MST1 kinase activity. I adopted an unbiased approach where the 
kinase of interest is applied to a library of peptides with fixed residues at particular 
locations (Hutti et al., 2004). This method takes advantage of a positional scanning 
peptide library consisting of 198 distinct peptide mixtures. In each mixture, one of the 20 
naturally occurring proteogenic amino acids was fixed at each of 9 positions surrounding 
a central serine/threonine residue, with the remaining positions degenerate. In addition, 
peptides were generated that had either phosphothreonine or phosphotyrosine at each of 
the fixed positions. Through applying the kinase and radioactive ATP to the substrates 
and measuring the amount of radioactivity, I can generate information regarding the 
sequence preference of kinases on substrates. 
 
Figure S9. MST1 shows a preference on substrate selection where histidine residues occupy the -
1 and -3 locations. Flag-MST1 immunoprecipitated from 293T cells and eluted using Flag peptide 
was subjected to in vitro kinase assay with radioactive p
32-ATP and the peptide library as  114 
 
Figure S9. continued 
described in Hutti et al. The stronger signal indicates a stronger preference on peptide sequence 
by MST1 kinase.  
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Interestingly, I observed a pattern of strong MST1 preference on the peptides 
where histidine residues precede the serine/threonine residue, including the -1 and -3 sites 
preceding the ser/thr residue (Figure S9).  
Future work will need to first validate the substrate preference by synthesizing a 
peptide with or without the histidine residues and testing whether mutating the histidine 
residue would significantly affect the substrate phosphorylation. After validation of this 
pattern, it would be interesting to scan potential substrates for this pattern to identify 
novel substrates that would like MST1 to interesting biological questions. 
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FoxA1 RNAi leads to altered Golgi and centrosomal location in cerebellar 
granule neurons 
During the process of studying the MST1-FoxA link, I observed an interesting 
phenotype in cerebellar granule neurons where knockdown of FoxA1 leads to retraction 
of dendrites and concomitant enlargement of the proximal segment of the axon. A high 
portion of transfected neurons (~50%) exhibited this axon thickening phenotype, whereas 
none of the control transfected neurons showed this phenotype (Figure S10).  
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Figure S10. continued 
Figure S10. FoxA1 RNAi leads to thickening of the proximal axon. (A) Representative image of 
the morphology of cerebellar granule neurons transfected with FoxA1 RNAi. Control (U6) cells 
have a thin axon extending out of the cell body, whereas FoxA1 RNAi leads to enlargement of 
the proximal axon with many protrusions. (B) Quantification of percent of neurons exhibiting the 
axonal phenotype induced by FoxA1 RNAi. Expression of RNAi resistant form of FoxA1 
reduced the percent of neurons exhibiting this phenotype. 
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The specification of neuronal axon and dendrites is an important aspect of neural 
development, and a lot of studies have tried to identify the molecular and cellular 
mechanisms underlying axonal and dendritic specification. On a cellular level, 
differential orientation of subcellular organelles seems to play a role in this polarization 
process. For example, orientation of the centrosome and Golgi apparatus specifies the 
location of axon formation before it turns to the other side and establishes the leading 
process for migration (de Anda et al., 2010; Wiggin et al., 2005). Therefore I examined 
the localization of the centrosome and Golgi apparatus to examine whether location 
might underlie the abnormal formation of axons and dendrites.  
Immunocytochemical analyses showed that under normal conditions, the 
centrosome is confined in the cell body, and the Golgi apparatus exhibits either an 
elongated or compact morphology in the soma, and occasionally with outposts in the 
dendritic arbors but never in the axon tracts. However, with FoxA1 RNAi, I observed a 
dramatic mislocalization of centrosome and the Golgi apparatus. The Golgi apparatus 
gets mislocalized into the axon, and interestingly, the location of the Golgi apparatus 
usually correlates with the site of enlargement along the axon (Figure S11A).  119 
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Figure S11. The Golgi apparatus and centrosome are mislocalized to the 
enlarged axons. 120 
 
 
Figure S11. continued 
Figure S11. The Golgi apparatus and centrosome are mislocalized to the enlarged axons. 
Cerebellar granule neurons are transfected with control or FoxA1 RNAi at DIV2 and subjected to 
immunocytochemistry at DIV5 with antibodies against GFP and GM130 (A) or GM130 and 
pericentrin (B). In control cells the Golgi apparatus (arrowhead in A) localizes to the cell body 
whereas FoxA1 RNAi leads to an axonal localization of the Golgi, which correlates with the site 
of axonal enlargement. The centrosome (arrowhead in B) also gets mislocalized into the enlarged 
axon segment, suggesting that abnormal positioning of subcellular organelles underlies the 
ectopic thickening of axons. 
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The centrosome is known to initiate the reorganization and polarization of the 
Golgi apparatus. Therefore, I also examined the localization of centrosomes in the 
transfected cells. Interestingly, I observed that in a high percentage of cells transfected 
with FoxA1 RNAi, at least one centriole is abnormally located in the enlarged segment of 
the axon. Quantification revealed that up to 20% of the FoxA1 RNAi transfected neurons 
exhibit an axonal localization of at least one centriole, whereas only less than 5% of 
control neurons show this phenotype (Figure S11B). 
I further performed live time imaging experiment to examine the cell biological 
basis for the thickened axon phenotype (Figure S12). Consistent with literature, control 
cells showed very dynamic remodeling of dendritic tree, whereas the axon remains a thin 
process extending out of the cell body that is relatively stable. However, neurons 
transfected with FoxA1 RNAi showed a collapse of dendritic tree and concomitant thickening 
of the axon.  Although preliminary, the data seems to suggest fusion of dendrites to the 
initial segment of the axon, or at least mis-delivery of dendritic materials to the axon 
initial segment. This idea of mis-delivery of dendritic materials to the axon initial 
segment is consistent with the mislocalization of centrosome and Golgi apparatus in the 
proximal axon, since the polarized orientation of these organelles is known to direct 
cargo transport along microtubules (Trimarchi et al., 2007). Further, more detailed time 
lapse imaging is needed to confirm this and better understand the underlying mechanisms 
involved. 
To summarize, I discovered a phenotype induced by FoxA1 RNAi in primary 
cultured cerebellar granule neurons where the proximal segment of the axon gets 
enlarged, and contains organelles such as the Golgi apparatus and centrosome. Future 122 
 
work will need to address both on a cellular and molecular level how this happens and 
what the physiological consequence of this phenotype is. 
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